,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
185,WikiPathways_2019_Human,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,2/53,0.0005274747206097833,0.0189890899419522,0,0,71.07308377896614,536.4176760073683,NRG1;PTK2
221,GO_Biological_Process_2017b,mammary gland fat development (GO:0060611),2/17,5.274920091662329e-05,0.0244756292253132,0,0,242.0848484848485,2384.5265424278687,ARID5B;NRG1
186,WikiPathways_2019_Human,ErbB Signaling Pathway WP673,2/91,0.0015458243502584,0.0278248383046524,0,0,40.64964249233912,263.0925328432116,NRG1;PTK2
164,KEGG_2019_Human,ErbB signaling pathway,2/85,0.0013506073370488,0.0283627540780261,0,0,43.6013143483023,288.08264376961074,NRG1;PTK2
232,GO_Biological_Process_2017b,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905312),2/145,0.0038638146103098,0.0538393549900015,0,0,25.23076923076923,140.18468556413987,CEMIP;PTK2
269,GO_Biological_Process_2017b,mammary gland development (GO:0030879),1/10,0.006482395492037,0.0538393549900015,0,0,184.9814814814815,932.059746399125,NRG1
268,GO_Biological_Process_2017b,negative regulation of cell-glial cell adhesion involved in cerebral cortex lamination (GO:0021821),1/10,0.006482395492037,0.0538393549900015,0,0,184.9814814814815,932.059746399125,PTK2
267,GO_Biological_Process_2017b,regulation of cell adhesion mediated by integrin (GO:0033628),1/10,0.006482395492037,0.0538393549900015,0,0,184.9814814814815,932.059746399125,PTK2
266,GO_Biological_Process_2017b,left ventricular trabecular myocardium morphogenesis (GO:0003225),1/10,0.006482395492037,0.0538393549900015,0,0,184.9814814814815,932.059746399125,NRG1
265,GO_Biological_Process_2017b,right ventricular trabecular myocardium morphogenesis (GO:0003227),1/10,0.006482395492037,0.0538393549900015,0,0,184.9814814814815,932.059746399125,NRG1
264,GO_Biological_Process_2017b,adipose tissue development (GO:0060612),1/9,0.005835902950749,0.0538393549900015,0,0,208.11458333333331,1070.4844511001115,ARID5B
263,GO_Biological_Process_2017b,fat pad development (GO:0060613),1/9,0.005835902950749,0.0538393549900015,0,0,208.11458333333331,1070.4844511001115,ARID5B
262,GO_Biological_Process_2017b,regulation of endothelial cell chemotaxis (GO:2001026),1/9,0.005835902950749,0.0538393549900015,0,0,208.11458333333331,1070.4844511001115,PTK2
261,GO_Biological_Process_2017b,positive regulation of cerebellar granule cell migration by calcium (GO:0021945),2/178,0.0057601131370258,0.0538393549900015,0,0,20.46590909090909,105.53856239639866,CEMIP;PTK2
260,GO_Biological_Process_2017b,positive regulation of epithelial cell migration (GO:0010634),2/172,0.0053891017442756,0.0538393549900015,0,0,21.194652406417116,110.70765058163104,CEMIP;PTK2
259,GO_Biological_Process_2017b,regulation of blood vessel endothelial cell migration (GO:0043535),1/8,0.0051890223794998,0.0538393549900015,0,0,237.8571428571429,1251.416370420653,PTK2
270,GO_Biological_Process_2017b,negative regulation of epithelial cell-cell adhesion involved in epithelium migration (GO:1903682),1/10,0.006482395492037,0.0538393549900015,0,0,184.9814814814815,932.059746399125,PTK2
271,GO_Biological_Process_2017b,delamination (GO:0060232),1/10,0.006482395492037,0.0538393549900015,0,0,184.9814814814815,932.059746399125,PTK2
272,GO_Biological_Process_2017b,thelarche (GO:0042695),1/10,0.006482395492037,0.0538393549900015,0,0,184.9814814814815,932.059746399125,NRG1
273,GO_Biological_Process_2017b,positive regulation of cell migration (GO:0030335),2/193,0.0067376943015652,0.0538393549900015,0,0,18.844359828653023,94.22250588855356,CEMIP;PTK2
274,GO_Biological_Process_2017b,negative regulation of calcium-independent cell-cell adhesion (GO:0051042),1/11,0.00712850018242,0.0538393549900015,0,0,166.475,822.994869532877,PTK2
275,GO_Biological_Process_2017b,cardiac pacemaker cell differentiation (GO:0060920),1/11,0.00712850018242,0.0538393549900015,0,0,166.475,822.994869532877,NRG1
276,GO_Biological_Process_2017b,negative regulation of homophilic cell adhesion (GO:1903386),1/11,0.00712850018242,0.0538393549900015,0,0,166.475,822.994869532877,PTK2
277,GO_Biological_Process_2017b,atrial cardiac muscle cell differentiation (GO:0055011),1/11,0.00712850018242,0.0538393549900015,0,0,166.475,822.994869532877,NRG1
278,GO_Biological_Process_2017b,cardiac neural crest cell development involved in heart development (GO:0061308),1/11,0.00712850018242,0.0538393549900015,0,0,166.475,822.994869532877,NRG1
279,GO_Biological_Process_2017b,His-Purkinje system cell differentiation (GO:0060932),1/11,0.00712850018242,0.0538393549900015,0,0,166.475,822.994869532877,NRG1
280,GO_Biological_Process_2017b,positive regulation of myotube differentiation (GO:0010831),1/11,0.00712850018242,0.0538393549900015,0,0,166.475,822.994869532877,NRG1
281,GO_Biological_Process_2017b,negative regulation of calcium-dependent cell-cell adhesion (GO:0046588),1/11,0.00712850018242,0.0538393549900015,0,0,166.475,822.994869532877,PTK2
282,GO_Biological_Process_2017b,ventricular cardiac muscle cell differentiation (GO:0055012),1/12,0.0077742172076079,0.0538393549900015,0,0,151.33333333333334,735.0172993440868,NRG1
283,GO_Biological_Process_2017b,placenta development (GO:0001890),1/12,0.0077742172076079,0.0538393549900015,0,0,151.33333333333334,735.0172993440868,PTK2
284,GO_Biological_Process_2017b,negative regulation of homotypic cell-cell adhesion (GO:0034111),1/12,0.0077742172076079,0.0538393549900015,0,0,151.33333333333334,735.0172993440868,PTK2
285,GO_Biological_Process_2017b,cardiac muscle cell myoblast differentiation (GO:0060379),1/12,0.0077742172076079,0.0538393549900015,0,0,151.33333333333334,735.0172993440868,NRG1
286,GO_Biological_Process_2017b,negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/12,0.0077742172076079,0.0538393549900015,0,0,151.33333333333334,735.0172993440868,PTK2
258,GO_Biological_Process_2017b,regulation of border follicle cell migration (GO:1903684),1/8,0.0051890223794998,0.0538393549900015,0,0,237.8571428571429,1251.416370420653,PTK2
257,GO_Biological_Process_2017b,regulation of endothelial cell migration (GO:0010594),1/8,0.0051890223794998,0.0538393549900015,0,0,237.8571428571429,1251.416370420653,PTK2
256,GO_Biological_Process_2017b,negative regulation of secretion (GO:0051048),1/8,0.0051890223794998,0.0538393549900015,0,0,237.8571428571429,1251.416370420653,NRG1
255,GO_Biological_Process_2017b,fat body development (GO:0007503),1/8,0.0051890223794998,0.0538393549900015,0,0,237.8571428571429,1251.416370420653,ARID5B
230,GO_Biological_Process_2017b,positive regulation of metanephric mesenchymal cell migration (GO:2000591),2/144,0.0038119164151337,0.0538393549900015,0,0,25.409731113956465,141.52262843147165,CEMIP;PTK2
229,GO_Biological_Process_2017b,positive regulation of distal tip cell migration (GO:1903356),2/144,0.0038119164151337,0.0538393549900015,0,0,25.409731113956465,141.52262843147165,CEMIP;PTK2
228,GO_Biological_Process_2017b,positive regulation of mesenchymal stem cell migration (GO:1905322),2/144,0.0038119164151337,0.0538393549900015,0,0,25.409731113956465,141.52262843147165,CEMIP;PTK2
227,GO_Biological_Process_2017b,positive regulation of neuroblast migration (GO:0061854),2/144,0.0038119164151337,0.0538393549900015,0,0,25.409731113956465,141.52262843147165,CEMIP;PTK2
226,GO_Biological_Process_2017b,positive regulation of formation of radial glial scaffolds (GO:0061926),2/144,0.0038119164151337,0.0538393549900015,0,0,25.409731113956465,141.52262843147165,CEMIP;PTK2
225,GO_Biological_Process_2017b,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),2/131,0.0031675778255332,0.0538393549900015,0,0,27.98872445384073,161.06917775087956,CEMIP;PTK2
224,GO_Biological_Process_2017b,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),2/126,0.0029348679574875,0.0538393549900015,0,0,29.124633431085044,169.82844075829703,NRG1;PTK2
223,GO_Biological_Process_2017b,ERBB2-EGFR signaling pathway (GO:0038134),2/73,0.0009986092713926314,0.0538393549900015,0,0,51.00128040973112,352.37534229207563,NRG1;PTK2
222,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway (GO:0007173),2/55,0.0005680161453256235,0.0538393549900015,0,0,68.38421955403088,511.05993992585104,NRG1;PTK2
233,GO_Biological_Process_2017b,positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),2/145,0.0038638146103098,0.0538393549900015,0,0,25.23076923076923,140.18468556413987,CEMIP;PTK2
234,GO_Biological_Process_2017b,positive regulation of glial cell migration (GO:1903977),2/145,0.0038638146103098,0.0538393549900015,0,0,25.23076923076923,140.18468556413987,CEMIP;PTK2
235,GO_Biological_Process_2017b,negative regulation of gastric acid secretion (GO:0060455),1/6,0.0038940964853966,0.0538393549900015,0,0,333.03333333333336,1847.7667100463036,NRG1
236,GO_Biological_Process_2017b,positive regulation of hematopoietic stem cell migration (GO:2000473),2/146,0.0039160442606156,0.0538393549900015,0,0,25.05429292929293,138.86775926373736,CEMIP;PTK2
237,GO_Biological_Process_2017b,positive regulation of smooth muscle cell migration (GO:0014911),2/148,0.0040214963875064,0.0538393549900015,0,0,24.70859277708593,136.2950985129956,CEMIP;PTK2
238,GO_Biological_Process_2017b,positive regulation of trophoblast cell migration (GO:1901165),2/148,0.0040214963875064,0.0538393549900015,0,0,24.70859277708593,136.2950985129956,CEMIP;PTK2
239,GO_Biological_Process_2017b,positive regulation of fibroblast chemotaxis (GO:1905212),2/149,0.0040747180957082,0.0538393549900015,0,0,24.53927025355597,135.03846837205694,CEMIP;PTK2
240,GO_Biological_Process_2017b,positive regulation of cell chemotaxis to fibroblast growth factor (GO:1904849),2/149,0.0040747180957082,0.0538393549900015,0,0,24.53927025355597,135.03846837205694,CEMIP;PTK2
254,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell differentiation (GO:2000727),1/8,0.0051890223794998,0.0538393549900015,0,0,237.8571428571429,1251.416370420653,NRG1
253,GO_Biological_Process_2017b,negative regulation of saliva secretion (GO:1905747),1/8,0.0051890223794998,0.0538393549900015,0,0,237.8571428571429,1251.416370420653,NRG1
252,GO_Biological_Process_2017b,positive regulation of neuron migration (GO:2001224),2/163,0.0048542893299164,0.0538393549900015,0,0,22.38961038961039,119.2894387719635,CEMIP;PTK2
251,GO_Biological_Process_2017b,negative regulation of renal sodium excretion (GO:0035814),1/7,0.0045417536091676,0.0538393549900015,0,0,277.5138888888889,1497.032601111507,NRG1
250,GO_Biological_Process_2017b,negative regulation of testosterone secretion (GO:2000844),1/7,0.0045417536091676,0.0538393549900015,0,0,277.5138888888889,1497.032601111507,NRG1
249,GO_Biological_Process_2017b,negative regulation of estradiol secretion (GO:2000865),1/7,0.0045417536091676,0.0538393549900015,0,0,277.5138888888889,1497.032601111507,NRG1
287,GO_Biological_Process_2017b,mammary gland morphogenesis (GO:0060443),1/12,0.0077742172076079,0.0538393549900015,0,0,151.33333333333334,735.0172993440868,NRG1
248,GO_Biological_Process_2017b,negative regulation of estrone secretion (GO:2000868),1/7,0.0045417536091676,0.0538393549900015,0,0,277.5138888888889,1497.032601111507,NRG1
246,GO_Biological_Process_2017b,negative regulation of dehydroepiandrosterone secretion (GO:2000841),1/7,0.0045417536091676,0.0538393549900015,0,0,277.5138888888889,1497.032601111507,NRG1
245,GO_Biological_Process_2017b,"positive regulation of wound healing, spreading of epidermal cells (GO:1903691)",2/156,0.0044564863052912,0.0538393549900015,0,0,23.415584415584416,126.75779934041768,CEMIP;PTK2
244,GO_Biological_Process_2017b,"positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)",2/155,0.0044009632132977,0.0538393549900015,0,0,23.56981580510992,127.8882142732826,CEMIP;PTK2
243,GO_Biological_Process_2017b,positive regulation of fibroblast migration (GO:0010763),2/152,0.0042363611949793,0.0538393549900015,0,0,24.044848484848483,131.38226847655596,CEMIP;PTK2
242,GO_Biological_Process_2017b,positive regulation of leukocyte migration (GO:0002687),2/151,0.0041821508832486,0.0538393549900015,0,0,24.20744356314826,132.58246417725604,CEMIP;PTK2
241,GO_Biological_Process_2017b,positive regulation of endothelial cell chemotaxis to vascular endothelial growth factor (GO:1904859),2/149,0.0040747180957082,0.0538393549900015,0,0,24.53927025355597,135.03846837205694,CEMIP;PTK2
247,GO_Biological_Process_2017b,negative regulation of androstenedione secretion (GO:2000838),1/7,0.0045417536091676,0.0538393549900015,0,0,277.5138888888889,1497.032601111507,NRG1
231,GO_Biological_Process_2017b,positive regulation of cell migration in other organism (GO:0044623),2/144,0.0038119164151337,0.0538393549900015,0,0,25.409731113956465,141.52262843147165,CEMIP;PTK2
0,GO_Biological_Process_2018,gland development (GO:0048732),2/75,0.0010536951813892,0.0558459776723505,0,0,49.59900373599004,340.0235929512583,ARID5B;NRG1
35,GO_Biological_Process_2018,protein O-linked glycosylation via threonine (GO:0018243),1/21,0.0135682578861655,0.0558459776723505,0,0,83.19583333333334,357.74392971285124,GALNTL6
28,GO_Biological_Process_2018,heart trabecula morphogenesis (GO:0061384),1/18,0.011640389286531,0.0558459776723505,0,0,97.8921568627451,435.94063546940737,NRG1
29,GO_Biological_Process_2018,regulation of adherens junction organization (GO:1903391),1/18,0.011640389286531,0.0558459776723505,0,0,97.8921568627451,435.94063546940737,PTK2
30,GO_Biological_Process_2018,striated muscle cell differentiation (GO:0051146),1/19,0.0122833981550328,0.0558459776723505,0,0,92.44907407407408,406.7303181925871,NRG1
31,GO_Biological_Process_2018,regulation of anoikis (GO:2000209),1/20,0.0129260209528938,0.0558459776723505,0,0,87.57894736842105,380.8381798737429,PTK2
32,GO_Biological_Process_2018,growth hormone receptor signaling pathway (GO:0060396),1/20,0.0129260209528938,0.0558459776723505,0,0,87.57894736842105,380.8381798737429,PTK2
33,GO_Biological_Process_2018,hyaluronan metabolic process (GO:0030212),1/21,0.0135682578861655,0.0558459776723505,0,0,83.19583333333334,357.74392971285124,CEMIP
34,GO_Biological_Process_2018,hepaticobiliary system development (GO:0061008),1/21,0.0135682578861655,0.0558459776723505,0,0,83.19583333333334,357.74392971285124,ARID5B
61,GO_Biological_Process_2018,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/33,0.0212450791356283,0.0558459776723505,0,0,51.966145833333336,200.1543652635479,PTK2
36,GO_Biological_Process_2018,MAPK cascade (GO:0000165),2/278,0.0135727817171936,0.0558459776723505,0,0,12.984848484848484,55.83080806654228,NRG1;PTK2
37,GO_Biological_Process_2018,protein O-linked glycosylation via serine (GO:0018242),1/22,0.0142101091631312,0.0558459776723505,0,0,79.23015873015873,337.0293803138913,GALNTL6
38,GO_Biological_Process_2018,regulation of ERBB signaling pathway (GO:1901184),1/22,0.0142101091631312,0.0558459776723505,0,0,79.23015873015873,337.0293803138913,NRG1
39,GO_Biological_Process_2018,positive regulation of protein targeting to membrane (GO:0090314),1/22,0.0142101091631312,0.0558459776723505,0,0,79.23015873015873,337.0293803138913,CEMIP
40,GO_Biological_Process_2018,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/22,0.0142101091631312,0.0558459776723505,0,0,79.23015873015873,337.0293803138913,PTK2
41,GO_Biological_Process_2018,mammary gland development (GO:0030879),1/24,0.0154926555661662,0.0558459776723505,0,0,72.33333333333333,301.441152263015,NRG1
42,GO_Biological_Process_2018,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),1/25,0.016133351108423,0.0558459776723505,0,0,69.31597222222223,286.05777422638903,PTK2
43,GO_Biological_Process_2018,positive regulation of calcium ion transmembrane transport (GO:1904427),1/25,0.016133351108423,0.0558459776723505,0,0,69.31597222222223,286.05777422638903,CEMIP
44,GO_Biological_Process_2018,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/25,0.016133351108423,0.0558459776723505,0,0,69.31597222222223,286.05777422638903,CEMIP
58,GO_Biological_Process_2018,positive regulation of calcium ion transport into cytosol (GO:0010524),1/32,0.0206074563833083,0.0558459776723505,0,0,53.64516129032258,208.25600447555712,CEMIP
57,GO_Biological_Process_2018,regulation of cell-cell adhesion (GO:0022407),1/32,0.0206074563833083,0.0558459776723505,0,0,53.64516129032258,208.25600447555712,PTK2
56,GO_Biological_Process_2018,negative regulation of cell-cell adhesion (GO:0022408),1/31,0.0199694502608653,0.0558459776723505,0,0,55.43611111111111,216.95208467294643,PTK2
55,GO_Biological_Process_2018,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/31,0.0199694502608653,0.0558459776723505,0,0,55.43611111111111,216.95208467294643,CEMIP
54,GO_Biological_Process_2018,liver development (GO:0001889),1/31,0.0199694502608653,0.0558459776723505,0,0,55.43611111111111,216.95208467294643,ARID5B
53,GO_Biological_Process_2018,regulation of cell adhesion mediated by integrin (GO:0033628),1/30,0.0193310605643026,0.0558459776723505,0,0,57.35057471264368,226.30778348154325,PTK2
27,GO_Biological_Process_2018,positive regulation of striated muscle cell differentiation (GO:0051155),1/17,0.0109969941425308,0.0558459776723505,0,0,104.015625,469.12433437564215,NRG1
52,GO_Biological_Process_2018,activation of protein kinase B activity (GO:0032148),1/30,0.0193310605643026,0.0558459776723505,0,0,57.35057471264368,226.30778348154325,NRG1
50,GO_Biological_Process_2018,carboxylic acid catabolic process (GO:0046395),1/28,0.0180531296002428,0.0558459776723505,0,0,61.60493827160494,247.30909578576168,CEMIP
49,GO_Biological_Process_2018,positive regulation of phospholipid metabolic process (GO:1903727),1/28,0.0180531296002428,0.0558459776723505,0,0,61.60493827160494,247.30909578576168,PTK2
48,GO_Biological_Process_2018,positive regulation of lipid kinase activity (GO:0090218),1/27,0.0174135879176465,0.0558459776723505,0,0,63.9775641025641,259.14140891073174,PTK2
47,GO_Biological_Process_2018,regulation of protein targeting to membrane (GO:0090313),1/27,0.0174135879176465,0.0558459776723505,0,0,63.9775641025641,259.14140891073174,CEMIP
46,GO_Biological_Process_2018,regulation of cell migration (GO:0030334),2/316,0.0173024117852967,0.0558459776723505,0,0,11.39143022582513,46.21400010788496,CEMIP;PTK2
45,GO_Biological_Process_2018,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/25,0.016133351108423,0.0558459776723505,0,0,69.31597222222223,286.05777422638903,PTK2
51,GO_Biological_Process_2018,connective tissue development (GO:0061448),1/30,0.0193310605643026,0.0558459776723505,0,0,57.35057471264368,226.30778348154325,ARID5B
59,GO_Biological_Process_2018,regulation of cell-substrate adhesion (GO:0010810),1/33,0.0212450791356283,0.0558459776723505,0,0,51.966145833333336,200.1543652635479,PTK2
26,GO_Biological_Process_2018,myoblast differentiation (GO:0045445),1/16,0.0103532125188836,0.0558459776723505,0,0,110.95555555555556,507.11775303850175,NRG1
24,GO_Biological_Process_2018,regulation of protein homodimerization activity (GO:0043496),1/16,0.0103532125188836,0.0558459776723505,0,0,110.95555555555556,507.11775303850175,NRG1
67,GO_Biological_Process_2018,regulation of cell morphogenesis involved in differentiation (GO:0010769),1/36,0.0231556492787795,0.0558459776723505,0,0,47.50476190476191,178.87996472866277,PTK2
66,GO_Biological_Process_2018,carbohydrate biosynthetic process (GO:0016051),1/36,0.0231556492787795,0.0558459776723505,0,0,47.50476190476191,178.87996472866277,GALNTL6
65,GO_Biological_Process_2018,cardiac muscle tissue development (GO:0048738),1/36,0.0231556492787795,0.0558459776723505,0,0,47.50476190476191,178.87996472866277,NRG1
64,GO_Biological_Process_2018,neural crest cell development (GO:0014032),1/35,0.0225191753740633,0.0558459776723505,0,0,48.90441176470589,185.51341332613868,NRG1
63,GO_Biological_Process_2018,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.0218823187292358,0.0558459776723505,0,0,50.388888888888886,192.59017962885017,NRG1
62,GO_Biological_Process_2018,positive regulation of muscle cell differentiation (GO:0051149),1/34,0.0218823187292358,0.0558459776723505,0,0,50.388888888888886,192.59017962885017,NRG1
1,GO_Biological_Process_2018,ERBB signaling pathway (GO:0038127),2/80,0.0011976875256538,0.0558459776723505,0,0,46.40792540792541,312.20294374307474,NRG1;PTK2
2,GO_Biological_Process_2018,positive regulation of protein kinase B signaling (GO:0051897),2/127,0.0029807338522071,0.0558459776723505,0,0,28.89018181818182,168.013329686665,NRG1;PTK2
3,GO_Biological_Process_2018,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.0038940964853966,0.0558459776723505,0,0,333.03333333333336,1847.7667100463036,NRG1
4,GO_Biological_Process_2018,positive regulation of intracellular protein transport (GO:0090316),2/152,0.0042363611949793,0.0558459776723505,0,0,24.044848484848483,131.38226847655596,CEMIP;NRG1
5,GO_Biological_Process_2018,regulation of protein heterodimerization activity (GO:0043497),1/7,0.0045417536091676,0.0558459776723505,0,0,277.5138888888889,1497.032601111507,NRG1
6,GO_Biological_Process_2018,hyaluronan biosynthetic process (GO:0030213),1/7,0.0045417536091676,0.0558459776723505,0,0,277.5138888888889,1497.032601111507,CEMIP
7,GO_Biological_Process_2018,regulation of protein kinase B signaling (GO:0051896),2/163,0.0048542893299164,0.0558459776723505,0,0,22.38961038961039,119.2894387719635,NRG1;PTK2
25,GO_Biological_Process_2018,hyaluronan catabolic process (GO:0030214),1/16,0.0103532125188836,0.0558459776723505,0,0,110.95555555555556,507.11775303850175,CEMIP
9,GO_Biological_Process_2018,regulation of striated muscle cell differentiation (GO:0051153),1/8,0.0051890223794998,0.0558459776723505,0,0,237.8571428571429,1251.416370420653,NRG1
8,GO_Biological_Process_2018,ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,0.0051890223794998,0.0558459776723505,0,0,237.8571428571429,1251.416370420653,NRG1
11,GO_Biological_Process_2018,adipose tissue development (GO:0060612),1/9,0.005835902950749,0.0558459776723505,0,0,208.11458333333331,1070.4844511001115,ARID5B
23,GO_Biological_Process_2018,mesenchymal cell development (GO:0014031),1/15,0.0097090442156726,0.0558459776723505,0,0,118.88690476190476,551.0048324972125,NRG1
22,GO_Biological_Process_2018,regulation of cell-substrate junction assembly (GO:0090109),1/15,0.0097090442156726,0.0558459776723505,0,0,118.88690476190476,551.0048324972125,PTK2
21,GO_Biological_Process_2018,cardiac muscle cell differentiation (GO:0055007),1/15,0.0097090442156726,0.0558459776723505,0,0,118.88690476190476,551.0048324972125,NRG1
20,GO_Biological_Process_2018,negative regulation of anoikis (GO:2000811),1/15,0.0097090442156726,0.0558459776723505,0,0,118.88690476190476,551.0048324972125,PTK2
10,GO_Biological_Process_2018,positive regulation of cell motility (GO:2000147),2/179,0.0058230667669009,0.0558459776723505,0,0,20.3492552645095,104.71580692420976,CEMIP;PTK2
18,GO_Biological_Process_2018,negative regulation of secretion (GO:0051048),1/14,0.0090644890278939,0.0558459776723505,0,0,128.03846153846155,602.2149225510485,NRG1
19,GO_Biological_Process_2018,neural crest cell differentiation (GO:0014033),1/15,0.0097090442156726,0.0558459776723505,0,0,118.88690476190476,551.0048324972125,NRG1
16,GO_Biological_Process_2018,regulation of secretion (GO:0051046),1/14,0.0090644890278939,0.0558459776723505,0,0,128.03846153846155,602.2149225510485,NRG1
15,GO_Biological_Process_2018,positive regulation of cell migration (GO:0030335),2/221,0.008750172912604,0.0558459776723505,0,0,16.41178912411789,77.77024671292564,CEMIP;PTK2
14,GO_Biological_Process_2018,cardiocyte differentiation (GO:0035051),1/13,0.0084195467572216,0.0558459776723505,0,0,138.71527777777777,662.6705253310397,NRG1
13,GO_Biological_Process_2018,placenta development (GO:0001890),1/13,0.0084195467572216,0.0558459776723505,0,0,138.71527777777777,662.6705253310397,PTK2
12,GO_Biological_Process_2018,cellular response to growth hormone stimulus (GO:0071378),1/10,0.006482395492037,0.0558459776723505,0,0,184.9814814814815,932.059746399125,PTK2
17,GO_Biological_Process_2018,stem cell development (GO:0048864),1/14,0.0090644890278939,0.0558459776723505,0,0,128.03846153846155,602.2149225510485,NRG1
60,GO_Biological_Process_2018,oligosaccharide biosynthetic process (GO:0009312),1/33,0.0212450791356283,0.0558459776723505,0,0,51.966145833333336,200.1543652635479,GALNTL6
68,GO_Biological_Process_2018,regulation of peptidyl-threonine phosphorylation (GO:0010799),1/37,0.0237917406507484,0.0565484850249672,0,0,46.18287037037037,172.65081800368927,CEMIP
69,GO_Biological_Process_2018,regulation of ossification (GO:0030278),1/38,0.0244274496995066,0.0572300250102728,0,0,44.93243243243244,166.7913365695687,PTK2
288,GO_Biological_Process_2017b,cardiac muscle cell development (GO:0055013),1/13,0.0084195467572216,0.05745102493163,0,0,138.71527777777777,662.6705253310397,NRG1
70,GO_Biological_Process_2018,ERBB2 signaling pathway (GO:0038128),1/39,0.0250627766358881,0.0578914840603612,0,0,43.74780701754386,161.27067055781572,NRG1
71,GO_Biological_Process_2018,negative regulation of transport (GO:0051051),1/40,0.0256977216686787,0.0585215472740972,0,0,42.623931623931625,156.0612574523752,NRG1
72,GO_Biological_Process_2018,regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/41,0.0263322850072555,0.0585215472740972,0,0,41.55625,151.13839929513645,PTK2
73,GO_Biological_Process_2018,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),2/396,0.0264060640139219,0.0585215472740972,0,0,9.041532071988923,32.85838864047874,NRG1;PTK2
74,GO_Biological_Process_2018,regulation of protein modification process (GO:0031399),1/42,0.0269664668566584,0.0589666741932263,0,0,40.540650406504064,146.47990317146446,PTK2
78,GO_Biological_Process_2018,positive regulation of protein phosphorylation (GO:0001934),2/412,0.0284192300670573,0.0589968826708532,0,0,8.68159645232816,30.91246714255668,CEMIP;PTK2
77,GO_Biological_Process_2018,regulation of focal adhesion assembly (GO:0051893),1/44,0.0282336869398409,0.0589968826708532,0,0,38.65116279069768,137.87795237211324,PTK2
76,GO_Biological_Process_2018,carboxylic acid biosynthetic process (GO:0046394),1/44,0.0282336869398409,0.0589968826708532,0,0,38.65116279069768,137.87795237211324,CEMIP
75,GO_Biological_Process_2018,negative regulation of ERBB signaling pathway (GO:1901185),1/43,0.027600267431624,0.0589968826708532,0,0,39.573412698412696,142.06577419675818,NRG1
79,GO_Biological_Process_2018,peptidyl-tyrosine autophosphorylation (GO:0038083),1/45,0.0288667255850808,0.0591767874494157,0,0,37.770833333333336,133.90008612704145,PTK2
290,GO_Biological_Process_2017b,positive regulation of sarcomere organization (GO:0060298),1/14,0.0090644890278939,0.0592383508301799,0,0,128.03846153846155,602.2149225510485,NRG1
291,GO_Biological_Process_2017b,negative regulation of ERBB3 signaling pathway (GO:1905579),1/14,0.0090644890278939,0.0592383508301799,0,0,128.03846153846155,602.2149225510485,NRG1
289,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),1/14,0.0090644890278939,0.0592383508301799,0,0,128.03846153846155,602.2149225510485,PTK2
292,GO_Biological_Process_2017b,MAPK cascade (GO:0000165),2/232,0.0096062377212789,0.0592762699483171,0,0,15.61818181818182,72.55180578559025,NRG1;PTK2
296,GO_Biological_Process_2017b,mesenchymal cell differentiation involved in mammary gland development (GO:0060610),1/15,0.0097090442156726,0.0592762699483171,0,0,118.88690476190476,551.0048324972125,NRG1
295,GO_Biological_Process_2017b,MAPK cascade involved in innate immune response (GO:0035420),2/232,0.0096062377212789,0.0592762699483171,0,0,15.61818181818182,72.55180578559025,NRG1;PTK2
294,GO_Biological_Process_2017b,MAPK cascade involved in osmosensory signaling pathway (GO:0000161),2/232,0.0096062377212789,0.0592762699483171,0,0,15.61818181818182,72.55180578559025,NRG1;PTK2
293,GO_Biological_Process_2017b,ERK5 cascade (GO:0070375),2/232,0.0096062377212789,0.0592762699483171,0,0,15.61818181818182,72.55180578559025,NRG1;PTK2
80,GO_Biological_Process_2018,regulation of cellular component movement (GO:0051270),1/46,0.0294993835815373,0.0597271470045941,0,0,36.92962962962963,130.1173367501014,NRG1
299,GO_Biological_Process_2017b,liver trabecula formation (GO:0060344),1/16,0.0103532125188836,0.0597461995201005,0,0,110.95555555555556,507.11775303850175,ARID5B
298,GO_Biological_Process_2017b,intrahepatic bile duct development (GO:0035622),1/16,0.0103532125188836,0.0597461995201005,0,0,110.95555555555556,507.11775303850175,ARID5B
352,GO_Biological_Process_2017b,positive regulation of germ cell proliferation (GO:1905938),2/327,0.0184555827281209,0.0597461995201005,0,0,10.99972027972028,43.91515528914248,NRG1;PTK2
351,GO_Biological_Process_2017b,positive regulation of leukocyte proliferation (GO:0070665),2/327,0.0184555827281209,0.0597461995201005,0,0,10.99972027972028,43.91515528914248,NRG1;PTK2
350,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in compound eye morphogenesis (GO:2000497),2/327,0.0184555827281209,0.0597461995201005,0,0,10.99972027972028,43.91515528914248,NRG1;PTK2
349,GO_Biological_Process_2017b,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091),2/327,0.0184555827281209,0.0597461995201005,0,0,10.99972027972028,43.91515528914248,NRG1;PTK2
348,GO_Biological_Process_2017b,positive regulation of mammary stem cell proliferation (GO:2000103),2/327,0.0184555827281209,0.0597461995201005,0,0,10.99972027972028,43.91515528914248,NRG1;PTK2
347,GO_Biological_Process_2017b,positive regulation of synoviocyte proliferation (GO:1901647),2/327,0.0184555827281209,0.0597461995201005,0,0,10.99972027972028,43.91515528914248,NRG1;PTK2
353,GO_Biological_Process_2017b,positive regulation of secondary heart field cardioblast proliferation (GO:0072513),2/328,0.0185620199428824,0.0597461995201005,0,0,10.965421081985498,43.71516134955577,NRG1;PTK2
346,GO_Biological_Process_2017b,positive regulation of cell proliferation in bone marrow (GO:0071864),2/327,0.0184555827281209,0.0597461995201005,0,0,10.99972027972028,43.91515528914248,NRG1;PTK2
344,GO_Biological_Process_2017b,positive regulation of skeletal muscle cell proliferation (GO:0014858),2/327,0.0184555827281209,0.0597461995201005,0,0,10.99972027972028,43.91515528914248,NRG1;PTK2
343,GO_Biological_Process_2017b,modulation by virus of host protein phosphorylation (GO:0039612),1/28,0.0180531296002428,0.0597461995201005,0,0,61.60493827160494,247.30909578576168,PTK2
341,GO_Biological_Process_2017b,positive regulation of protein kinase C activity (GO:1900020),1/27,0.0174135879176465,0.0597461995201005,0,0,63.9775641025641,259.14140891073174,CEMIP
340,GO_Biological_Process_2017b,negative regulation of ERBB signaling pathway (GO:1901185),1/27,0.0174135879176465,0.0597461995201005,0,0,63.9775641025641,259.14140891073174,NRG1
339,GO_Biological_Process_2017b,regulation of cell motility (GO:2000145),1/27,0.0174135879176465,0.0597461995201005,0,0,63.9775641025641,259.14140891073174,NRG1
338,GO_Biological_Process_2017b,regulation of flagellated sperm motility (GO:1901317),1/26,0.0167736618234459,0.0597461995201005,0,0,66.54,272.01188501169923,NRG1
345,GO_Biological_Process_2017b,positive regulation of sebum secreting cell proliferation (GO:1904004),2/327,0.0184555827281209,0.0597461995201005,0,0,10.99972027972028,43.91515528914248,NRG1;PTK2
337,GO_Biological_Process_2017b,positive regulation of striated muscle cell differentiation (GO:0051155),1/26,0.0167736618234459,0.0597461995201005,0,0,66.54,272.01188501169923,NRG1
354,GO_Biological_Process_2017b,positive regulation of hemocyte proliferation (GO:0035208),2/328,0.0185620199428824,0.0597461995201005,0,0,10.965421081985498,43.71516134955577,NRG1;PTK2
356,GO_Biological_Process_2017b,positive regulation of hair follicle cell proliferation (GO:0071338),2/328,0.0185620199428824,0.0597461995201005,0,0,10.965421081985498,43.71516134955577,NRG1;PTK2
370,GO_Biological_Process_2017b,positive regulation of osteoblast proliferation (GO:0033690),2/335,0.0193145041552049,0.0597461995201005,0,0,10.73109473109473,42.3545465767474,NRG1;PTK2
369,GO_Biological_Process_2017b,positive regulation of neural precursor cell proliferation (GO:2000179),2/335,0.0193145041552049,0.0597461995201005,0,0,10.73109473109473,42.3545465767474,NRG1;PTK2
368,GO_Biological_Process_2017b,positive regulation of trophectodermal cell proliferation (GO:1904075),2/335,0.0193145041552049,0.0597461995201005,0,0,10.73109473109473,42.3545465767474,NRG1;PTK2
367,GO_Biological_Process_2017b,positive regulation of stem cell proliferation (GO:2000648),2/334,0.019206213342437,0.0597461995201005,0,0,10.76396495071194,42.54480225478374,NRG1;PTK2
366,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell proliferation (GO:0060045),2/334,0.019206213342437,0.0597461995201005,0,0,10.76396495071194,42.54480225478374,NRG1;PTK2
365,GO_Biological_Process_2017b,positive regulation of myoblast proliferation (GO:2000288),2/330,0.0187756914348666,0.0597461995201005,0,0,10.897450110864744,43.31945927545843,NRG1;PTK2
355,GO_Biological_Process_2017b,positive regulation of chorionic trophoblast cell proliferation (GO:1901384),2/328,0.0185620199428824,0.0597461995201005,0,0,10.965421081985498,43.71516134955577,NRG1;PTK2
364,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in kidney development (GO:1901724),2/330,0.0187756914348666,0.0597461995201005,0,0,10.897450110864744,43.31945927545843,NRG1;PTK2
362,GO_Biological_Process_2017b,positive regulation of glial cell proliferation (GO:0060252),2/330,0.0187756914348666,0.0597461995201005,0,0,10.897450110864744,43.31945927545843,NRG1;PTK2
361,GO_Biological_Process_2017b,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/29,0.0186922870807393,0.0597461995201005,0,0,59.40178571428572,236.3979776770167,PTK2
360,GO_Biological_Process_2017b,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/29,0.0186922870807393,0.0597461995201005,0,0,59.40178571428572,236.3979776770167,PTK2
359,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138),2/329,0.0186687229563166,0.0597461995201005,0,0,10.93133166527662,43.51660080388817,NRG1;PTK2
358,GO_Biological_Process_2017b,positive regulation of mesenchymal cell proliferation (GO:0002053),2/329,0.0186687229563166,0.0597461995201005,0,0,10.93133166527662,43.51660080388817,NRG1;PTK2
357,GO_Biological_Process_2017b,positive regulation of fat cell proliferation (GO:0070346),2/328,0.0185620199428824,0.0597461995201005,0,0,10.965421081985498,43.71516134955577,NRG1;PTK2
363,GO_Biological_Process_2017b,positive regulation of chondrocyte proliferation (GO:1902732),2/330,0.0187756914348666,0.0597461995201005,0,0,10.897450110864744,43.31945927545843,NRG1;PTK2
336,GO_Biological_Process_2017b,modulation by symbiont of host cell motility (GO:1903653),1/26,0.0167736618234459,0.0597461995201005,0,0,66.54,272.01188501169923,NRG1
335,GO_Biological_Process_2017b,regulation of bacterial-type flagellum-dependent cell motility (GO:1902021),1/26,0.0167736618234459,0.0597461995201005,0,0,66.54,272.01188501169923,NRG1
333,GO_Biological_Process_2017b,regulation of amoeboid sperm motility (GO:1905416),1/26,0.0167736618234459,0.0597461995201005,0,0,66.54,272.01188501169923,NRG1
313,GO_Biological_Process_2017b,negative regulation of cytoskeleton organization (GO:0051494),1/19,0.0122833981550328,0.0597461995201005,0,0,92.44907407407408,406.7303181925871,PTK2
312,GO_Biological_Process_2017b,regulation of intermediate filament polymerization or depolymerization (GO:0045108),1/19,0.0122833981550328,0.0597461995201005,0,0,92.44907407407408,406.7303181925871,PTK2
311,GO_Biological_Process_2017b,liver morphogenesis (GO:0072576),1/19,0.0122833981550328,0.0597461995201005,0,0,92.44907407407408,406.7303181925871,ARID5B
310,GO_Biological_Process_2017b,negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/19,0.0122833981550328,0.0597461995201005,0,0,92.44907407407408,406.7303181925871,PTK2
309,GO_Biological_Process_2017b,regulation of focal adhesion assembly (GO:0051893),1/19,0.0122833981550328,0.0597461995201005,0,0,92.44907407407408,406.7303181925871,PTK2
308,GO_Biological_Process_2017b,positive regulation of protein targeting to vacuolar membrane (GO:1900485),1/19,0.0122833981550328,0.0597461995201005,0,0,92.44907407407408,406.7303181925871,CEMIP
314,GO_Biological_Process_2017b,apoptotic process involved in heart morphogenesis (GO:0003278),1/20,0.0129260209528938,0.0597461995201005,0,0,87.57894736842105,380.8381798737429,PTK2
307,GO_Biological_Process_2017b,cardiac muscle cell fate commitment (GO:0060923),1/18,0.011640389286531,0.0597461995201005,0,0,97.8921568627451,435.94063546940737,NRG1
305,GO_Biological_Process_2017b,stress-activated MAPK cascade (GO:0051403),2/250,0.0110849119456192,0.0597461995201005,0,0,14.47140762463343,65.15274275739714,NRG1;PTK2
304,GO_Biological_Process_2017b,regulation of protein heterodimerization activity (GO:0043497),1/17,0.0109969941425308,0.0597461995201005,0,0,104.015625,469.12433437564215,NRG1
303,GO_Biological_Process_2017b,mammary gland epithelium development (GO:0061180),1/17,0.0109969941425308,0.0597461995201005,0,0,104.015625,469.12433437564215,NRG1
302,GO_Biological_Process_2017b,liver development (GO:0001889),1/17,0.0109969941425308,0.0597461995201005,0,0,104.015625,469.12433437564215,ARID5B
301,GO_Biological_Process_2017b,ERK1 and ERK2 cascade (GO:0070371),2/245,0.0106645694575861,0.0597461995201005,0,0,14.772914328469884,67.08126741974317,NRG1;PTK2
300,GO_Biological_Process_2017b,regulation of protein homodimerization activity (GO:0043496),1/16,0.0103532125188836,0.0597461995201005,0,0,110.95555555555556,507.11775303850175,NRG1
306,GO_Biological_Process_2017b,liver regeneration (GO:0097421),1/18,0.011640389286531,0.0597461995201005,0,0,97.8921568627451,435.94063546940737,ARID5B
315,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion mediated by integrin (GO:0033633),1/20,0.0129260209528938,0.0597461995201005,0,0,87.57894736842105,380.8381798737429,PTK2
316,GO_Biological_Process_2017b,MAPK import into nucleus (GO:0000189),2/273,0.0131120364638965,0.0597461995201005,0,0,13.227775914122777,57.33215251881658,NRG1;PTK2
317,GO_Biological_Process_2017b,regulation of cytoskeleton organization (GO:0051493),1/21,0.0135682578861655,0.0597461995201005,0,0,83.19583333333334,357.74392971285124,PTK2
332,GO_Biological_Process_2017b,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/25,0.016133351108423,0.0597461995201005,0,0,69.31597222222223,286.05777422638903,PTK2
331,GO_Biological_Process_2017b,positive regulation of cytoskeleton organization (GO:0051495),1/25,0.016133351108423,0.0597461995201005,0,0,69.31597222222223,286.05777422638903,PTK2
330,GO_Biological_Process_2017b,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239),1/25,0.016133351108423,0.0597461995201005,0,0,69.31597222222223,286.05777422638903,PTK2
329,GO_Biological_Process_2017b,regulation of peptidyl-serine phosphorylation (GO:0033135),1/24,0.0154926555661662,0.0597461995201005,0,0,72.33333333333333,301.441152263015,PTK2
328,GO_Biological_Process_2017b,regulation of histone phosphorylation (GO:0033127),1/24,0.0154926555661662,0.0597461995201005,0,0,72.33333333333333,301.441152263015,PTK2
327,GO_Biological_Process_2017b,lactation (GO:0007595),1/24,0.0154926555661662,0.0597461995201005,0,0,72.33333333333333,301.441152263015,NRG1
326,GO_Biological_Process_2017b,regulation of protein autophosphorylation (GO:0031952),1/23,0.0148515749863377,0.0597461995201005,0,0,75.625,318.3547328251434,PTK2
325,GO_Biological_Process_2017b,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),1/23,0.0148515749863377,0.0597461995201005,0,0,75.625,318.3547328251434,PTK2
324,GO_Biological_Process_2017b,growth involved in heart morphogenesis (GO:0003241),1/22,0.0142101091631312,0.0597461995201005,0,0,79.23015873015873,337.0293803138913,PTK2
323,GO_Biological_Process_2017b,neural crest cell migration (GO:0001755),1/22,0.0142101091631312,0.0597461995201005,0,0,79.23015873015873,337.0293803138913,NRG1
322,GO_Biological_Process_2017b,cardiac muscle cell differentiation (GO:0055007),1/21,0.0135682578861655,0.0597461995201005,0,0,83.19583333333334,357.74392971285124,NRG1
321,GO_Biological_Process_2017b,heart formation (GO:0060914),1/21,0.0135682578861655,0.0597461995201005,0,0,83.19583333333334,357.74392971285124,PTK2
320,GO_Biological_Process_2017b,regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/21,0.0135682578861655,0.0597461995201005,0,0,83.19583333333334,357.74392971285124,PTK2
319,GO_Biological_Process_2017b,regulation of peptidyl-threonine phosphorylation (GO:0010799),1/21,0.0135682578861655,0.0597461995201005,0,0,83.19583333333334,357.74392971285124,PTK2
318,GO_Biological_Process_2017b,neural crest cell development (GO:0014032),1/21,0.0135682578861655,0.0597461995201005,0,0,83.19583333333334,357.74392971285124,NRG1
297,GO_Biological_Process_2017b,MAPK cascade involved in axon regeneration (GO:1903616),2/237,0.0100073499489767,0.0597461995201005,0,0,15.28201160541586,70.36503615241246,NRG1;PTK2
334,GO_Biological_Process_2017b,regulation of cilium-dependent cell motility (GO:1902019),1/26,0.0167736618234459,0.0597461995201005,0,0,66.54,272.01188501169923,NRG1
342,GO_Biological_Process_2017b,positive regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061903),1/28,0.0180531296002428,0.0597461995201005,0,0,61.60493827160494,247.30909578576168,PTK2
372,GO_Biological_Process_2017b,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/31,0.0199694502608653,0.0597795156196227,0,0,55.43611111111111,216.95208467294643,CEMIP
375,GO_Biological_Process_2017b,regulation of protein phosphorylation (GO:0001932),1/31,0.0199694502608653,0.0597795156196227,0,0,55.43611111111111,216.95208467294643,PTK2
374,GO_Biological_Process_2017b,ventricular trabecula myocardium morphogenesis (GO:0003222),1/31,0.0199694502608653,0.0597795156196227,0,0,55.43611111111111,216.95208467294643,NRG1
373,GO_Biological_Process_2017b,regulation of osteoblast differentiation (GO:0045667),1/31,0.0199694502608653,0.0597795156196227,0,0,55.43611111111111,216.95208467294643,PTK2
371,GO_Biological_Process_2017b,positive regulation of growth plate cartilage chondrocyte proliferation (GO:0061913),2/337,0.0195318758569481,0.0597795156196227,0,0,10.665943012211669,41.97803178702879,NRG1;PTK2
81,GO_Biological_Process_2018,positive regulation of cell proliferation (GO:0008284),2/424,0.0299692738768507,0.0599385477537015,0,0,8.429556225764756,29.567364964746105,NRG1;PTK2
380,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation (GO:0050679),2/348,0.0207461399644575,0.0601638058969268,0,0,10.321071991592223,39.998231569268206,NRG1;PTK2
379,GO_Biological_Process_2017b,positive regulation of smooth muscle cell proliferation (GO:0048661),2/347,0.0206344498465417,0.0601638058969268,0,0,10.351515151515152,40.17209041000823,NRG1;PTK2
378,GO_Biological_Process_2017b,regulation of I-kappaB phosphorylation (GO:1903719),1/32,0.0206074563833083,0.0601638058969268,0,0,53.64516129032258,208.25600447555712,PTK2
377,GO_Biological_Process_2017b,regulation of cell motility involved in somitogenic axis elongation (GO:0090249),1/32,0.0206074563833083,0.0601638058969268,0,0,53.64516129032258,208.25600447555712,NRG1
376,GO_Biological_Process_2017b,positive regulation of fibroblast proliferation (GO:0048146),2/345,0.0204118484584014,0.0601638058969268,0,0,10.41293400477074,40.52338778244838,NRG1;PTK2
82,GO_Biological_Process_2018,regulation of epithelial cell migration (GO:0010632),1/48,0.0307635584593973,0.0607858263535079,0,0,35.354609929078016,123.08440365356886,PTK2
86,GO_Biological_Process_2018,negative regulation of nucleic acid-templated transcription (GO:1903507),2/444,0.0326276039926827,0.0608607189117875,0,0,8.039901275195392,27.51733877409941,ARID5B;NRG1
85,GO_Biological_Process_2018,wound healing (GO:0042060),1/50,0.032026213248763,0.0608607189117875,0,0,33.90816326530612,116.6847899929619,NRG1
84,GO_Biological_Process_2018,heart morphogenesis (GO:0003007),1/50,0.032026213248763,0.0608607189117875,0,0,33.90816326530612,116.6847899929619,PTK2
83,GO_Biological_Process_2018,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/49,0.0313950757631915,0.0608607189117875,0,0,34.61631944444444,119.81068935137382,CEMIP
87,GO_Biological_Process_2018,peptidyl-tyrosine modification (GO:0018212),1/51,0.0326569711233982,0.0608607189117875,0,0,33.22833333333333,113.69728633442386,PTK2
88,GO_Biological_Process_2018,regulation of cell-matrix adhesion (GO:0001952),1/52,0.0332873496068505,0.0613384869159942,0,0,32.57516339869281,110.83952930563026,PTK2
89,GO_Biological_Process_2018,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/53,0.0339173488988434,0.0618049468823369,0,0,31.947115384615383,108.10356363888964,PTK2
187,WikiPathways_2019_Human,FTO Obesity Variant Mechanism WP3407,1/8,0.0051890223794998,0.0622682685539983,0,0,237.8571428571429,1251.416370420653,ARID5B
381,GO_Biological_Process_2017b,negative regulation of endothelial cell migration (GO:0010596),1/34,0.0218823187292358,0.0630645707476113,0,0,50.388888888888886,192.59017962885017,PTK2
90,GO_Biological_Process_2018,glycosaminoglycan catabolic process (GO:0006027),1/56,0.0358050737240217,0.0645278251729623,0,0,30.2,100.5559032787779,CEMIP
91,GO_Biological_Process_2018,epidermal growth factor receptor signaling pathway (GO:0007173),1/57,0.0364335583389396,0.0649467779085446,0,0,29.65922619047619,98.23921673902151,PTK2
383,GO_Biological_Process_2017b,wound healing (GO:0042060),1/36,0.0231556492787795,0.0651164925172951,0,0,47.50476190476191,178.87996472866277,NRG1
384,GO_Biological_Process_2017b,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/36,0.0231556492787795,0.0651164925172951,0,0,47.50476190476191,178.87996472866277,PTK2
382,GO_Biological_Process_2017b,epiboly involved in wound healing (GO:0090505),1/36,0.0231556492787795,0.0651164925172951,0,0,47.50476190476191,178.87996472866277,NRG1
385,GO_Biological_Process_2017b,JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),1/36,0.0231556492787795,0.0651164925172951,0,0,47.50476190476191,178.87996472866277,PTK2
92,GO_Biological_Process_2018,integrin-mediated signaling pathway (GO:0007229),1/58,0.0370616648121668,0.0653560540773695,0,0,29.1374269005848,96.0128372683442,PTK2
93,GO_Biological_Process_2018,positive regulation of intracellular signal transduction (GO:1902533),2/479,0.0374984768551742,0.0654228745132826,0,0,7.43663045549838,24.41784118473329,NRG1;PTK2
407,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase V promoter (GO:1904280),2/412,0.0284192300670573,0.0656389237909264,0,0,8.68159645232816,30.91246714255668,ARID5B;NRG1
406,GO_Biological_Process_2017b,negative regulation of antisense RNA transcription (GO:0060195),2/412,0.0284192300670573,0.0656389237909264,0,0,8.68159645232816,30.91246714255668,ARID5B;NRG1
405,GO_Biological_Process_2017b,nitrogen catabolite repression of transcription (GO:0090295),2/412,0.0284192300670573,0.0656389237909264,0,0,8.68159645232816,30.91246714255668,ARID5B;NRG1
404,GO_Biological_Process_2017b,regulation of protein kinase activity (GO:0045859),1/44,0.0282336869398409,0.0656389237909264,0,0,38.65116279069768,137.87795237211324,PTK2
403,GO_Biological_Process_2017b,activation of protein kinase B activity (GO:0032148),1/44,0.0282336869398409,0.0656389237909264,0,0,38.65116279069768,137.87795237211324,NRG1
402,GO_Biological_Process_2017b,positive regulation of protein histidine kinase activity (GO:0010864),1/43,0.027600267431624,0.0656389237909264,0,0,39.573412698412696,142.06577419675818,PTK2
401,GO_Biological_Process_2017b,determination of liver left/right asymmetry (GO:0071910),1/43,0.027600267431624,0.0656389237909264,0,0,39.573412698412696,142.06577419675818,ARID5B
400,GO_Biological_Process_2017b,hyaluronan biosynthetic process (GO:0030213),1/43,0.027600267431624,0.0656389237909264,0,0,39.573412698412696,142.06577419675818,CEMIP
399,GO_Biological_Process_2017b,hyaluronan catabolic process (GO:0030214),1/41,0.0263322850072555,0.0656389237909264,0,0,41.55625,151.13839929513645,CEMIP
398,GO_Biological_Process_2017b,ERBB2 signaling pathway (GO:0038128),1/41,0.0263322850072555,0.0656389237909264,0,0,41.55625,151.13839929513645,NRG1
387,GO_Biological_Process_2017b,wound healing involved in inflammatory response (GO:0002246),1/37,0.0237917406507484,0.0656389237909264,0,0,46.18287037037037,172.65081800368927,NRG1
396,GO_Biological_Process_2017b,"positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587)",1/40,0.0256977216686787,0.0656389237909264,0,0,42.623931623931625,156.0612574523752,CEMIP
395,GO_Biological_Process_2017b,regulation of microtubule cytoskeleton organization (GO:0070507),1/39,0.0250627766358881,0.0656389237909264,0,0,43.74780701754386,161.27067055781572,PTK2
394,GO_Biological_Process_2017b,cardiac muscle tissue morphogenesis (GO:0055008),1/39,0.0250627766358881,0.0656389237909264,0,0,43.74780701754386,161.27067055781572,PTK2
393,GO_Biological_Process_2017b,ERBB2-ERBB3 signaling pathway (GO:0038133),1/39,0.0250627766358881,0.0656389237909264,0,0,43.74780701754386,161.27067055781572,NRG1
392,GO_Biological_Process_2017b,negative regulation of cell motility (GO:2000146),1/39,0.0250627766358881,0.0656389237909264,0,0,43.74780701754386,161.27067055781572,NRG1
391,GO_Biological_Process_2017b,embryonic heart tube morphogenesis (GO:0003143),1/38,0.0244274496995066,0.0656389237909264,0,0,44.93243243243244,166.7913365695687,PTK2
408,GO_Biological_Process_2017b,"negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated (GO:0010678)",2/412,0.0284192300670573,0.0656389237909264,0,0,8.68159645232816,30.91246714255668,ARID5B;NRG1
390,GO_Biological_Process_2017b,endocardial cushion morphogenesis (GO:0003203),1/38,0.0244274496995066,0.0656389237909264,0,0,44.93243243243244,166.7913365695687,PTK2
389,GO_Biological_Process_2017b,ERBB2-ERBB4 signaling pathway (GO:0038135),1/38,0.0244274496995066,0.0656389237909264,0,0,44.93243243243244,166.7913365695687,NRG1
388,GO_Biological_Process_2017b,angiogenesis involved in wound healing (GO:0060055),1/38,0.0244274496995066,0.0656389237909264,0,0,44.93243243243244,166.7913365695687,NRG1
386,GO_Biological_Process_2017b,negative regulation of focal adhesion assembly (GO:0051895),1/37,0.0237917406507484,0.0656389237909264,0,0,46.18287037037037,172.65081800368927,PTK2
397,GO_Biological_Process_2017b,positive regulation of protein targeting to membrane (GO:0090314),1/41,0.0263322850072555,0.0656389237909264,0,0,41.55625,151.13839929513645,CEMIP
416,GO_Biological_Process_2017b,carbon catabolite repression of transcription (GO:0045013),2/413,0.0285470950539525,0.0656389237909264,0,0,8.66003096660031,30.79680296760964,ARID5B;NRG1
411,GO_Biological_Process_2017b,"negative regulation of mating-type specific transcription, DNA-templated (GO:0045894)",2/412,0.0284192300670573,0.0656389237909264,0,0,8.68159645232816,30.91246714255668,ARID5B;NRG1
410,GO_Biological_Process_2017b,negative regulation of ncRNA transcription associated with protein coding gene TSS/TES (GO:1904388),2/412,0.0284192300670573,0.0656389237909264,0,0,8.68159645232816,30.91246714255668,ARID5B;NRG1
433,GO_Biological_Process_2017b,regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735),1/47,0.030131661136783,0.0656389237909264,0,0,36.125,126.5162089708299,PTK2
432,GO_Biological_Process_2017b,positive regulation of tau-protein kinase activity (GO:1902949),1/47,0.030131661136783,0.0656389237909264,0,0,36.125,126.5162089708299,PTK2
431,GO_Biological_Process_2017b,positive regulation of cell motility (GO:2000147),1/47,0.030131661136783,0.0656389237909264,0,0,36.125,126.5162089708299,NRG1
430,GO_Biological_Process_2017b,regulation of epithelial cell migration (GO:0010632),1/47,0.030131661136783,0.0656389237909264,0,0,36.125,126.5162089708299,PTK2
429,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, initiation (GO:2000143)",2/424,0.0299692738768507,0.0656389237909264,0,0,8.429556225764756,29.567364964746105,ARID5B;NRG1
428,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase III promoter (GO:0016480),2/423,0.0298388039209993,0.0656389237909264,0,0,8.450010796804145,29.67597813238637,ARID5B;NRG1
427,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",2/422,0.0297085692322699,0.0656389237909264,0,0,8.47056277056277,29.78520715061645,ARID5B;NRG1
426,GO_Biological_Process_2017b,enzyme active site formation via O4'-phospho-L-tyrosine (GO:0018334),1/46,0.0294993835815373,0.0656389237909264,0,0,36.92962962962963,130.1173367501014,PTK2
425,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081),2/419,0.0293192798407747,0.0656389237909264,0,0,8.532810115543928,30.1166383263995,NRG1;PTK2
424,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase I promoter (GO:0016479),2/419,0.0293192798407747,0.0656389237909264,0,0,8.532810115543928,30.1166383263995,ARID5B;NRG1
409,GO_Biological_Process_2017b,negative regulation of transcription by pheromones (GO:0045996),2/412,0.0284192300670573,0.0656389237909264,0,0,8.68159645232816,30.91246714255668,ARID5B;NRG1
422,GO_Biological_Process_2017b,plasma membrane repair (GO:0001778),1/45,0.0288667255850808,0.0656389237909264,0,0,37.770833333333336,133.90008612704145,NRG1
421,GO_Biological_Process_2017b,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/45,0.0288667255850808,0.0656389237909264,0,0,37.770833333333336,133.90008612704145,PTK2
420,GO_Biological_Process_2017b,regulation of eIF2 alpha phosphorylation by heme (GO:0010999),1/45,0.0288667255850808,0.0656389237909264,0,0,37.770833333333336,133.90008612704145,PTK2
419,GO_Biological_Process_2017b,positive regulation of focal adhesion assembly (GO:0051894),1/45,0.0288667255850808,0.0656389237909264,0,0,37.770833333333336,133.90008612704145,PTK2
418,GO_Biological_Process_2017b,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734),1/45,0.0288667255850808,0.0656389237909264,0,0,37.770833333333336,133.90008612704145,PTK2
417,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, termination (GO:0060567)",2/414,0.0286751984090233,0.0656389237909264,0,0,8.63857016769638,30.68180573213554,ARID5B;NRG1
415,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor catabolism (GO:0010620),2/413,0.0285470950539525,0.0656389237909264,0,0,8.66003096660031,30.79680296760964,ARID5B;NRG1
414,GO_Biological_Process_2017b,negative regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090419),2/413,0.0285470950539525,0.0656389237909264,0,0,8.66003096660031,30.79680296760964,ARID5B;NRG1
413,GO_Biological_Process_2017b,chromatin organization involved in negative regulation of transcription (GO:0097549),2/412,0.0284192300670573,0.0656389237909264,0,0,8.68159645232816,30.91246714255668,ARID5B;NRG1
423,GO_Biological_Process_2017b,negative regulation of transcription by competitive promoter binding (GO:0010944),2/416,0.0289321189850027,0.0656389237909264,0,0,8.595959595959595,30.45379073466877,ARID5B;NRG1
412,GO_Biological_Process_2017b,negative regulation of transcription during mitotic cell cycle (GO:0007068),2/412,0.0284192300670573,0.0656389237909264,0,0,8.68159645232816,30.91246714255668,ARID5B;NRG1
434,GO_Biological_Process_2017b,negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),2/430,0.0307570168480664,0.0663920517449319,0,0,8.308836023789295,28.92835192923719,ARID5B;NRG1
435,GO_Biological_Process_2017b,negative regulation of cell adhesion mediated by integrin (GO:0033629),1/48,0.0307635584593973,0.0663920517449319,0,0,35.354609929078016,123.08440365356886,PTK2
452,GO_Biological_Process_2017b,gurken signaling pathway (GO:0008314),1/52,0.0332873496068505,0.0665746992137011,0,0,32.57516339869281,110.83952930563026,PTK2
451,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway involved in heart process (GO:1905251),1/52,0.0332873496068505,0.0665746992137011,0,0,32.57516339869281,110.83952930563026,PTK2
450,GO_Biological_Process_2017b,ERBB4-EGFR signaling pathway (GO:0038137),1/52,0.0332873496068505,0.0665746992137011,0,0,32.57516339869281,110.83952930563026,PTK2
449,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway involved in lung development (GO:0060507),1/52,0.0332873496068505,0.0665746992137011,0,0,32.57516339869281,110.83952930563026,PTK2
448,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity (GO:0038167),1/52,0.0332873496068505,0.0665746992137011,0,0,32.57516339869281,110.83952930563026,PTK2
447,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway via MAPK cascade (GO:0038029),1/52,0.0332873496068505,0.0665746992137011,0,0,32.57516339869281,110.83952930563026,PTK2
446,GO_Biological_Process_2017b,epidermal growth factor signaling pathway involved in forebrain neuron fate commitment (GO:0022026),1/52,0.0332873496068505,0.0665746992137011,0,0,32.57516339869281,110.83952930563026,PTK2
443,GO_Biological_Process_2017b,positive regulation of cell proliferation (GO:0008284),2/442,0.0323576118706475,0.0665746992137011,0,0,8.077272727272728,27.712363369300387,NRG1;PTK2
444,GO_Biological_Process_2017b,activation of signaling protein activity involved in unfolded protein response (GO:0006987),1/51,0.0326569711233982,0.0665746992137011,0,0,33.22833333333333,113.69728633442386,PTK2
442,GO_Biological_Process_2017b,regulation of GTPase activity (GO:0043087),1/50,0.032026213248763,0.0665746992137011,0,0,33.90816326530612,116.6847899929619,PTK2
441,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion (GO:0022408),1/50,0.032026213248763,0.0665746992137011,0,0,33.90816326530612,116.6847899929619,PTK2
440,GO_Biological_Process_2017b,negative regulation of protein homodimerization activity (GO:0090074),1/50,0.032026213248763,0.0665746992137011,0,0,33.90816326530612,116.6847899929619,NRG1
439,GO_Biological_Process_2017b,regulation of inhibitory G-protein coupled receptor phosphorylation (GO:1904323),1/50,0.032026213248763,0.0665746992137011,0,0,33.90816326530612,116.6847899929619,PTK2
438,GO_Biological_Process_2017b,heterotrimeric G-protein complex cycle (GO:0031684),1/50,0.032026213248763,0.0665746992137011,0,0,33.90816326530612,116.6847899929619,PTK2
437,GO_Biological_Process_2017b,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/49,0.0313950757631915,0.0665746992137011,0,0,34.61631944444444,119.81068935137382,NRG1
445,GO_Biological_Process_2017b,positive regulation of protein homodimerization activity (GO:0090073),1/51,0.0326569711233982,0.0665746992137011,0,0,33.22833333333333,113.69728633442386,NRG1
436,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor localization (GO:0010621),2/432,0.0310214659627899,0.0665746992137011,0,0,8.269344608879493,28.72006116986248,ARID5B;NRG1
453,GO_Biological_Process_2017b,histone-tyrosine phosphorylation (GO:0035406),1/54,0.0345469692098807,0.0679228547177316,0,0,31.342767295597483,105.4820602978719,PTK2
454,GO_Biological_Process_2017b,positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),1/54,0.0345469692098807,0.0679228547177316,0,0,31.342767295597483,105.4820602978719,CEMIP
455,GO_Biological_Process_2017b,cardiac epithelial to mesenchymal transition (GO:0060317),1/54,0.0345469692098807,0.0679228547177316,0,0,31.342767295597483,105.4820602978719,PTK2
456,GO_Biological_Process_2017b,integrin-mediated signaling pathway (GO:0007229),1/54,0.0345469692098807,0.0679228547177316,0,0,31.342767295597483,105.4820602978719,PTK2
457,GO_Biological_Process_2017b,negative regulation of osteoblast differentiation (GO:0045668),1/56,0.0358050737240217,0.0692231425331088,0,0,30.2,100.5559032787779,PTK2
458,GO_Biological_Process_2017b,regulation of MAPK cascade (GO:0043408),1/56,0.0358050737240217,0.0692231425331088,0,0,30.2,100.5559032787779,PTK2
460,GO_Biological_Process_2017b,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/56,0.0358050737240217,0.0692231425331088,0,0,30.2,100.5559032787779,PTK2
459,GO_Biological_Process_2017b,regulation of actin cytoskeleton organization (GO:0032956),1/56,0.0358050737240217,0.0692231425331088,0,0,30.2,100.5559032787779,PTK2
94,GO_Biological_Process_2018,oligosaccharide metabolic process (GO:0009311),1/63,0.040196532223731,0.0693919082599146,0,0,26.780913978494624,86.07317595715509,GALNTL6
95,GO_Biological_Process_2018,O-glycan processing (GO:0016266),1/65,0.0414478394284331,0.0700767594460106,0,0,25.94140625,82.57978498333833,GALNTL6
96,GO_Biological_Process_2018,negative regulation of cell adhesion (GO:0007162),1/65,0.0414478394284331,0.0700767594460106,0,0,25.94140625,82.57978498333833,PTK2
97,GO_Biological_Process_2018,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/512,0.0423362211354588,0.0708483700634208,0,0,6.943672014260249,21.95667045931643,ARID5B;NRG1
461,GO_Biological_Process_2017b,regulation of actin phosphorylation (GO:0043538),1/58,0.0370616648121668,0.071355238476537,0,0,29.1374269005848,96.0128372683442,PTK2
98,GO_Biological_Process_2018,positive regulation of cellular process (GO:0048522),2/519,0.0433919785263267,0.0713577601573818,0,0,6.847195357833655,21.48294315793791,NRG1;PTK2
100,GO_Biological_Process_2018,regulation of osteoblast differentiation (GO:0045667),1/69,0.0439459376578998,0.0713577601573818,0,0,24.410539215686278,76.2779330882361,PTK2
99,GO_Biological_Process_2018,regulation of endothelial cell migration (GO:0010594),1/69,0.0439459376578998,0.0713577601573818,0,0,24.410539215686278,76.2779330882361,PTK2
192,WikiPathways_2019_Human,PI3K-Akt Signaling Pathway WP4172,2/340,0.0198599036322099,0.0716148612956809,0,0,10.569661108122649,41.42305650173658,COL6A5;PTK2
193,WikiPathways_2019_Human,Alpha 6 Beta 4 signaling pathway WP244,1/33,0.0212450791356283,0.0716148612956809,0,0,51.966145833333336,200.1543652635479,PTK2
194,WikiPathways_2019_Human,Prion disease pathway WP3995,1/33,0.0212450791356283,0.0716148612956809,0,0,51.966145833333336,200.1543652635479,PTK2
195,WikiPathways_2019_Human,Signaling of Hepatocyte Growth Factor Receptor WP313,1/34,0.0218823187292358,0.0716148612956809,0,0,50.388888888888886,192.59017962885017,PTK2
190,WikiPathways_2019_Human,Angiogenesis WP1539,1/24,0.0154926555661662,0.0716148612956809,0,0,72.33333333333333,301.441152263015,PTK2
188,WikiPathways_2019_Human,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,1/13,0.0084195467572216,0.0716148612956809,0,0,138.71527777777777,662.6705253310397,PTK2
189,WikiPathways_2019_Human,Overview of nanoparticle effects WP3287,1/19,0.0122833981550328,0.0716148612956809,0,0,92.44907407407408,406.7303181925871,PTK2
191,WikiPathways_2019_Human,Nanoparticle-mediated activation of receptor signaling WP2643,1/28,0.0180531296002428,0.0716148612956809,0,0,61.60493827160494,247.30909578576168,PTK2
101,GO_Biological_Process_2018,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/70,0.044569522553697,0.0716608009686893,0,0,24.05555555555556,74.82973704934292,PTK2
165,KEGG_2019_Human,Focal adhesion,2/199,0.0071485363517022,0.0750596316928731,0,0,18.26488232579603,90.244000903913,COL6A5;PTK2
462,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387),2/491,0.0392307025246394,0.0752191982290607,0,0,7.249674660717606,23.476589635553008,ARID5B;PTK2
463,GO_Biological_Process_2017b,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),1/62,0.0395703133756882,0.0755581292441125,0,0,27.22131147540984,87.91601919409594,PTK2
102,GO_Biological_Process_2018,transforming growth factor beta receptor signaling pathway (GO:0007179),1/76,0.0483031547149421,0.0769098774101991,0,0,22.12444444444445,67.04278374363157,PTK2
108,GO_Biological_Process_2018,positive regulation of protein targeting to mitochondrion (GO:1903955),1/81,0.0514042221710775,0.0773421324408873,0,0,20.73645833333333,61.54653341446361,NRG1
107,GO_Biological_Process_2018,sensory perception of sound (GO:0007605),1/81,0.0514042221710775,0.0773421324408873,0,0,20.73645833333333,61.54653341446361,CEMIP
106,GO_Biological_Process_2018,regulation of hydrolase activity (GO:0051336),1/80,0.0507847558615241,0.0773421324408873,0,0,21.0,62.58334006884147,PTK2
105,GO_Biological_Process_2018,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/80,0.0507847558615241,0.0773421324408873,0,0,21.0,62.58334006884147,PTK2
103,GO_Biological_Process_2018,sensory perception of mechanical stimulus (GO:0050954),1/78,0.0495447028828492,0.0773421324408873,0,0,21.547619047619047,64.74800798109044,CEMIP
104,GO_Biological_Process_2018,peptidyl-tyrosine phosphorylation (GO:0018108),1/79,0.0501649161718136,0.0773421324408873,0,0,21.270299145299145,63.650080736899376,PTK2
109,GO_Biological_Process_2018,ephrin receptor signaling pathway (GO:0048013),1/82,0.0520233153027185,0.077562033724053,0,0,20.47942386831276,60.53847309097546,PTK2
110,GO_Biological_Process_2018,positive regulation of protein ubiquitination (GO:0031398),1/83,0.0526420354551319,0.0777774217535282,0,0,20.228658536585368,59.55803218916631,PTK2
465,GO_Biological_Process_2017b,activation of protein kinase activity (GO:0032147),1/66,0.0420729281997368,0.0796809742231751,0,0,25.54102564102564,80.9229285312976,PTK2
464,GO_Biological_Process_2017b,regulation of cell migration (GO:0030334),1/66,0.0420729281997368,0.0796809742231751,0,0,25.54102564102564,80.9229285312976,NRG1
466,GO_Biological_Process_2017b,positive regulation of protein kinase B signaling (GO:0051897),1/67,0.0426976406866875,0.0800852485098929,0,0,25.15277777777778,79.3220921121178,PTK2
467,GO_Biological_Process_2017b,positive regulation of osteoblast differentiation (GO:0045669),1/68,0.0433219771034119,0.0800852485098929,0,0,24.776119402985078,77.77459794803441,PTK2
469,GO_Biological_Process_2017b,vascular endothelial growth factor receptor signaling pathway involved in lymphatic endothelial cell fate commitment (GO:0060851),1/68,0.0433219771034119,0.0800852485098929,0,0,24.776119402985078,77.77459794803441,PTK2
470,GO_Biological_Process_2017b,vascular endothelial growth factor receptor-1 signaling pathway (GO:0036323),1/68,0.0433219771034119,0.0800852485098929,0,0,24.776119402985078,77.77459794803441,PTK2
471,GO_Biological_Process_2017b,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/68,0.0433219771034119,0.0800852485098929,0,0,24.776119402985078,77.77459794803441,PTK2
468,GO_Biological_Process_2017b,vascular endothelial growth factor receptor-3 signaling pathway (GO:0036325),1/68,0.0433219771034119,0.0800852485098929,0,0,24.776119402985078,77.77459794803441,PTK2
111,GO_Biological_Process_2018,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),1/87,0.0551131904457131,0.0807014574383656,0,0,19.28391472868217,55.89184666184607,PTK2
112,GO_Biological_Process_2018,regulation of protein targeting to mitochondrion (GO:1903214),1/88,0.0557300488159362,0.0808825487240137,0,0,19.061302681992338,55.03447552600268,NRG1
472,GO_Biological_Process_2017b,sensory perception of sound (GO:0007605),1/69,0.0439459376578998,0.0809163296558155,0,0,24.410539215686278,76.2779330882361,CEMIP
113,GO_Biological_Process_2018,peptidyl-threonine modification (GO:0018210),1/89,0.0563465354488023,0.0810599281895051,0,0,18.84375,54.19904429476309,GALNTL6
474,GO_Biological_Process_2017b,vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324),1/70,0.044569522553697,0.0814183404130528,0,0,24.05555555555556,74.82973704934292,PTK2
473,GO_Biological_Process_2017b,negative regulation of GTPase activity (GO:0034260),1/70,0.044569522553697,0.0814183404130528,0,0,24.05555555555556,74.82973704934292,PTK2
483,GO_Biological_Process_2017b,transforming growth factor beta receptor signaling pathway involved in primitive streak formation (GO:0090010),1/73,0.04643802536608,0.0819286835355936,0,0,23.04976851851852,70.7544140609547,PTK2
482,GO_Biological_Process_2017b,transforming growth factor beta receptor signaling pathway involved in primary germ layer cell fate commitment (GO:0060797),1/73,0.04643802536608,0.0819286835355936,0,0,23.04976851851852,70.7544140609547,PTK2
481,GO_Biological_Process_2017b,transforming growth factor beta receptor signaling pathway involved in heart development (GO:1905313),1/73,0.04643802536608,0.0819286835355936,0,0,23.04976851851852,70.7544140609547,PTK2
480,GO_Biological_Process_2017b,transforming growth factor receptor beta signaling pathway involved in oral/aboral axis specification (GO:0060835),1/73,0.04643802536608,0.0819286835355936,0,0,23.04976851851852,70.7544140609547,PTK2
479,GO_Biological_Process_2017b,detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),1/73,0.04643802536608,0.0819286835355936,0,0,23.04976851851852,70.7544140609547,CEMIP
477,GO_Biological_Process_2017b,positive regulation of endothelial cell migration (GO:0010595),1/72,0.0458155662055763,0.0819286835355936,0,0,23.37558685446009,72.0700051727417,PTK2
476,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/72,0.0458155662055763,0.0819286835355936,0,0,23.37558685446009,72.0700051727417,NRG1
475,GO_Biological_Process_2017b,hepatocyte differentiation (GO:0070365),1/72,0.0458155662055763,0.0819286835355936,0,0,23.37558685446009,72.0700051727417,ARID5B
478,GO_Biological_Process_2017b,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),1/73,0.04643802536608,0.0819286835355936,0,0,23.04976851851852,70.7544140609547,PTK2
484,GO_Biological_Process_2017b,transforming growth factor beta receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060826),1/74,0.0470601097064945,0.0823995883162772,0,0,22.732876712328768,69.47916318158998,PTK2
485,GO_Biological_Process_2017b,tyrosine phosphorylation of STAT protein (GO:0007260),1/74,0.0470601097064945,0.0823995883162772,0,0,22.732876712328768,69.47916318158998,PTK2
196,WikiPathways_2019_Human,Cardiac Progenitor Differentiation WP2406,1/53,0.0339173488988434,0.0828054080827579,0,0,31.947115384615383,108.10356363888964,NRG1
197,WikiPathways_2019_Human,RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway WP2018,1/55,0.0351762107497116,0.0828054080827579,0,0,30.760802469135804,102.96825664265003,PTK2
198,WikiPathways_2019_Human,Cardiac Hypertrophic Response WP2795,1/55,0.0351762107497116,0.0828054080827579,0,0,30.760802469135804,102.96825664265003,NRG1
199,WikiPathways_2019_Human,MET in type 1 papillary renal cell carcinoma WP4205,1/59,0.0376893933426092,0.0828054080827579,0,0,28.63362068965517,93.87179112052809,PTK2
200,WikiPathways_2019_Human,Pathways Affected in Adenoid Cystic Carcinoma WP3651,1/65,0.0414478394284331,0.0828054080827579,0,0,25.94140625,82.57978498333833,ARID5B
201,WikiPathways_2019_Human,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,1/66,0.0420729281997368,0.0828054080827579,0,0,25.54102564102564,80.9229285312976,PTK2
202,WikiPathways_2019_Human,RAC1/PAK1/p38/MMP2 Pathway WP3303,1/68,0.0433219771034119,0.0828054080827579,0,0,24.776119402985078,77.77459794803441,PTK2
203,WikiPathways_2019_Human,Primary Focal Segmental Glomerulosclerosis FSGS WP2572,1/72,0.0458155662055763,0.0828054080827579,0,0,23.37558685446009,72.0700051727417,PTK2
204,WikiPathways_2019_Human,Prolactin Signaling Pathway WP2037,1/76,0.0483031547149421,0.0828054080827579,0,0,22.12444444444445,67.04278374363157,PTK2
205,WikiPathways_2019_Human,Leptin signaling pathway WP2034,1/76,0.0483031547149421,0.0828054080827579,0,0,22.12444444444445,67.04278374363157,PTK2
487,GO_Biological_Process_2017b,ERBB signaling pathway (GO:0038127),1/76,0.0483031547149421,0.0839425610027458,0,0,22.12444444444445,67.04278374363157,NRG1
486,GO_Biological_Process_2017b,negative regulation of protein phosphorylation (GO:0001933),1/76,0.0483031547149421,0.0839425610027458,0,0,22.12444444444445,67.04278374363157,PTK2
116,GO_Biological_Process_2018,regulation of cytoskeleton organization (GO:0051493),1/95,0.0600376601458919,0.0841553526831306,0,0,17.63563829787234,49.60522791144115,PTK2
115,GO_Biological_Process_2018,positive regulation of protein localization to membrane (GO:1905477),1/95,0.0600376601458919,0.0841553526831306,0,0,17.63563829787234,49.60522791144115,CEMIP
114,GO_Biological_Process_2018,negative regulation of gene expression (GO:0010629),2/618,0.0593627598536175,0.0841553526831306,0,0,5.717532467532467,16.146815904423654,ARID5B;NRG1
117,GO_Biological_Process_2018,glycosaminoglycan biosynthetic process (GO:0006024),1/99,0.0624910010872804,0.0868518998162202,0,0,16.912414965986393,46.89360626939404,CEMIP
118,GO_Biological_Process_2018,cellular response to transforming growth factor beta stimulus (GO:0071560),1/100,0.0631034120924418,0.0869660469173148,0,0,16.74074074074074,46.254339159717055,PTK2
206,WikiPathways_2019_Human,MicroRNAs in cardiomyocyte hypertrophy WP1544,1/84,0.0532603828402292,0.0871533537385569,0,0,19.983935742971887,58.60414077176453,NRG1
488,GO_Biological_Process_2017b,regulation of eIF2 alpha phosphorylation by amino acid starvation (GO:0060733),1/80,0.0507847558615241,0.0875989840882795,0,0,21.0,62.58334006884147,PTK2
489,GO_Biological_Process_2017b,growth hormone receptor signaling pathway (GO:0060396),1/80,0.0507847558615241,0.0875989840882795,0,0,21.0,62.58334006884147,PTK2
208,WikiPathways_2019_Human,Corticotropin-releasing hormone signaling pathway WP2355,1/93,0.0588087686569903,0.0882131529854855,0,0,18.02083333333333,51.06138805719774,PTK2
207,WikiPathways_2019_Human,Androgen receptor signaling pathway WP138,1/90,0.0569626505406045,0.0882131529854855,0,0,18.631086142322097,53.384759293029546,PTK2
490,GO_Biological_Process_2017b,transforming growth factor beta receptor signaling pathway involved in regulation of multicellular organism growth (GO:1901048),1/82,0.0520233153027185,0.0890731302600051,0,0,20.47942386831276,60.53847309097546,PTK2
491,GO_Biological_Process_2017b,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/82,0.0520233153027185,0.0890731302600051,0,0,20.47942386831276,60.53847309097546,NRG1
492,GO_Biological_Process_2017b,activation of Janus kinase activity (GO:0042976),1/83,0.0526420354551319,0.0898011193058132,0,0,20.228658536585368,59.55803218916631,PTK2
494,GO_Biological_Process_2017b,activation of MAPK activity involved in cell wall organization or biogenesis (GO:0000199),1/84,0.0532603828402292,0.0898647914104231,0,0,19.983935742971887,58.60414077176453,NRG1
493,GO_Biological_Process_2017b,activation of MAPK activity involved in osmosensory signaling pathway (GO:0000169),1/84,0.0532603828402292,0.0898647914104231,0,0,19.983935742971887,58.60414077176453,NRG1
495,GO_Biological_Process_2017b,activation of MAPK activity involved in conjugation with cellular fusion (GO:0071508),1/84,0.0532603828402292,0.0898647914104231,0,0,19.983935742971887,58.60414077176453,NRG1
168,KEGG_2019_Human,PI3K-Akt signaling pathway,2/354,0.0214217119138352,0.0899711900381081,0,0,10.142045454545457,38.97943339850745,COL6A5;PTK2
167,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0199694502608653,0.0899711900381081,0,0,55.43611111111111,216.95208467294643,GALNTL6
166,KEGG_2019_Human,Human papillomavirus infection,2/330,0.0187756914348666,0.0899711900381081,0,0,10.897450110864744,43.31945927545843,COL6A5;PTK2
496,GO_Biological_Process_2017b,activation of MAPK activity involved in innate immune response (GO:0035419),1/86,0.0544959601278673,0.0916163967367046,0,0,19.511764705882356,56.77199069596926,NRG1
209,WikiPathways_2019_Human,Integrin-mediated Cell Adhesion WP185,1/101,0.0637154538039526,0.0917502534776918,0,0,16.5725,45.62953064886561,PTK2
497,GO_Biological_Process_2017b,hepatoblast differentiation (GO:0061017),1/87,0.0551131904457131,0.0923195681112306,0,0,19.28391472868217,55.89184666184607,ARID5B
498,GO_Biological_Process_2017b,positive regulation of protein import into mitochondrial outer membrane (GO:1903638),1/89,0.0563465354488023,0.0933742587437296,0,0,18.84375,54.19904429476309,NRG1
499,GO_Biological_Process_2017b,transforming growth factor beta receptor complex assembly (GO:0007181),1/89,0.0563465354488023,0.0933742587437296,0,0,18.84375,54.19904429476309,PTK2
500,GO_Biological_Process_2017b,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),1/89,0.0563465354488023,0.0933742587437296,0,0,18.84375,54.19904429476309,ARID5B
119,GO_Biological_Process_2018,regulation of cell motility (GO:2000145),1/109,0.068598517731233,0.0937513075660184,0,0,15.338734567901234,41.09989925264156,NRG1
120,GO_Biological_Process_2018,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/110,0.0692072450617056,0.0938015552902456,0,0,15.19724770642202,40.58652539902874,NRG1
121,GO_Biological_Process_2018,regulation of protein binding (GO:0043393),1/111,0.069815605123331,0.0938504855756253,0,0,15.058333333333334,40.08374324378988,NRG1
123,GO_Biological_Process_2018,positive regulation of kinase activity (GO:0033674),1/113,0.0710312243296769,0.0939445225005404,0,0,14.787946428571429,39.108731340452245,PTK2
122,GO_Biological_Process_2018,regulation of organelle organization (GO:0033043),1/113,0.0710312243296769,0.0939445225005404,0,0,14.787946428571429,39.108731340452245,PTK2
501,GO_Biological_Process_2017b,activation of MAPK activity by adrenergic receptor signaling pathway (GO:0071883),1/90,0.0569626505406045,0.0940593233125996,0,0,18.631086142322097,53.384759293029546,NRG1
502,GO_Biological_Process_2017b,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/91,0.0575783943051017,0.0947389182892453,0,0,18.423148148148147,52.59086388764015,NRG1
124,GO_Biological_Process_2018,protein O-linked glycosylation (GO:0006493),1/115,0.0722453769721048,0.0947859345874016,0,0,14.527046783625732,38.17253111855829,GALNTL6
503,GO_Biological_Process_2017b,positive regulation of hh target transcription factor activity (GO:0007228),1/92,0.0581937669386946,0.0954131019772237,0,0,18.21978021978022,51.81663638666002,ARID5B
125,GO_Biological_Process_2018,activation of MAPK activity (GO:0000187),1/117,0.0734580646669198,0.0956120841696416,0,0,14.27514367816092,37.27297949092863,NRG1
126,GO_Biological_Process_2018,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/118,0.0740638596731147,0.0956415195778803,0,0,14.152421652421651,36.8363135332588,CEMIP
127,GO_Biological_Process_2018,regulation of phosphorylation (GO:0042325),1/119,0.0746692890506965,0.0956700265962049,0,0,14.03177966101695,36.40806778684625,PTK2
128,GO_Biological_Process_2018,enzyme linked receptor protein signaling pathway (GO:0007167),1/120,0.0752743529888432,0.0956976270555836,0,0,13.913165266106445,35.98801310463489,PTK2
129,GO_Biological_Process_2018,regulation of cell differentiation (GO:0045595),1/121,0.0758790517068621,0.0957243421532722,0,0,13.796527777777778,35.575928388462685,PTK2
504,GO_Biological_Process_2017b,positive regulation of androgen receptor activity (GO:2000825),1/95,0.0600376601458919,0.0977455238866451,0,0,17.63563829787234,49.60522791144115,ARID5B
505,GO_Biological_Process_2017b,negative regulation of epithelial cell migration (GO:0010633),1/95,0.0600376601458919,0.0977455238866451,0,0,17.63563829787234,49.60522791144115,PTK2
506,GO_Biological_Process_2017b,heart morphogenesis (GO:0003007),1/96,0.0606515503312197,0.0983997180198809,0,0,17.449122807017545,48.903087500760165,PTK2
130,GO_Biological_Process_2018,cytoskeleton organization (GO:0007010),1/126,0.0788970740354205,0.0987719094794578,0,0,13.241333333333332,33.62783759261686,PTK2
507,GO_Biological_Process_2017b,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),1/97,0.0612650704056327,0.0990487549415108,0,0,17.266493055555557,48.2174659702364,PTK2
131,GO_Biological_Process_2018,positive regulation of mitochondrion organization (GO:0010822),1/128,0.0801017334683338,0.0995203355212632,0,0,13.031496062992126,32.897461671293605,NRG1
508,GO_Biological_Process_2017b,transforming growth factor beta receptor signaling pathway involved in determination of left/right asymmetry (GO:0035463),1/98,0.0618782205955173,0.0996926887372224,0,0,17.087628865979383,47.54781410425205,PTK2
509,GO_Biological_Process_2017b,positive regulation of thyroid hormone receptor activity (GO:1904169),1/99,0.0624910010872804,0.0999856017396487,0,0,16.912414965986393,46.89360626939404,ARID5B
510,GO_Biological_Process_2017b,phosphatidylinositol-mediated signaling (GO:0048015),1/99,0.0624910010872804,0.0999856017396487,0,0,16.912414965986393,46.89360626939404,NRG1
132,GO_Biological_Process_2018,regulation of cell proliferation (GO:0042127),2/740,0.0814392453803057,0.1004213251306025,0,0,4.74230105937423,11.89320730512612,NRG1;PTK2
133,GO_Biological_Process_2018,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/133,0.0831070223634688,0.1016638390885054,0,0,12.53472222222222,31.1817018518508,PTK2
134,GO_Biological_Process_2018,Fc-gamma receptor signaling pathway (GO:0038094),1/134,0.0837069915156922,0.1016638390885054,0,0,12.43984962406015,30.856210715153104,PTK2
135,GO_Biological_Process_2018,Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/135,0.0843065982685166,0.1016638390885054,0,0,12.346393034825873,30.53627396070408,PTK2
511,GO_Biological_Process_2017b,positive regulation of CREB transcription factor activity (GO:0032793),1/103,0.0649384302010941,0.1035444385337033,0,0,16.24591503267974,44.42146030184692,ARID5B
512,GO_Biological_Process_2017b,transforming growth factor beta receptor signaling pathway (GO:0007179),1/104,0.0655493652791092,0.1041606352380366,0,0,16.0873786407767,43.83733060942407,PTK2
210,WikiPathways_2019_Human,Hippo-Merlin Signaling Dysregulation WP4541,1/120,0.0752743529888432,0.1042260272153214,0,0,13.913165266106445,35.98801310463489,PTK2
513,GO_Biological_Process_2017b,planar cell polarity pathway involved in heart morphogenesis (GO:0061346),1/106,0.066770130249167,0.1057383632614795,0,0,15.77936507936508,42.70684291496826,PTK2
526,GO_Biological_Process_2017b,regulation of glial cell proliferation (GO:0060251),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
536,GO_Biological_Process_2017b,regulation of chorionic trophoblast cell proliferation (GO:1901382),1/122,0.0764833854144393,0.1058894710236663,0,0,13.681818181818182,35.17160025020979,PTK2
537,GO_Biological_Process_2017b,regulation of fibroblast proliferation (GO:0048145),1/122,0.0764833854144393,0.1058894710236663,0,0,13.681818181818182,35.17160025020979,PTK2
538,GO_Biological_Process_2017b,regulation of cell proliferation involved in tissue homeostasis (GO:0060784),1/122,0.0764833854144393,0.1058894710236663,0,0,13.681818181818182,35.17160025020979,PTK2
539,GO_Biological_Process_2017b,regulation of cytoskeleton polarization involved in growth plate cartilage chondrocyte division (GO:0003427),1/122,0.0764833854144393,0.1058894710236663,0,0,13.681818181818182,35.17160025020979,PTK2
540,GO_Biological_Process_2017b,regulation of cell proliferation involved in heart morphogenesis (GO:2000136),1/122,0.0764833854144393,0.1058894710236663,0,0,13.681818181818182,35.17160025020979,PTK2
541,GO_Biological_Process_2017b,regulation of cell proliferation involved in compound eye morphogenesis (GO:2000495),1/122,0.0764833854144393,0.1058894710236663,0,0,13.681818181818182,35.17160025020979,PTK2
542,GO_Biological_Process_2017b,positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),1/122,0.0764833854144393,0.1058894710236663,0,0,13.681818181818182,35.17160025020979,PTK2
543,GO_Biological_Process_2017b,regulation of epithelial cell proliferation (GO:0050678),1/122,0.0764833854144393,0.1058894710236663,0,0,13.681818181818182,35.17160025020979,PTK2
544,GO_Biological_Process_2017b,regulation of myoblast proliferation (GO:2000291),1/123,0.0770873542947081,0.1058894710236663,0,0,13.568989071038253,34.77482268580042,PTK2
533,GO_Biological_Process_2017b,regulation of mammary stem cell proliferation (GO:2000101),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
514,GO_Biological_Process_2017b,positive regulation of protein tyrosine kinase activity (GO:0061098),1/109,0.068598517731233,0.1058894710236663,0,0,15.338734567901234,41.09989925264156,PTK2
515,GO_Biological_Process_2017b,positive regulation of inhibitory G-protein coupled receptor phosphorylation (GO:1904325),1/113,0.0710312243296769,0.1058894710236663,0,0,14.787946428571429,39.108731340452245,PTK2
516,GO_Biological_Process_2017b,positive regulation of protein targeting to mitochondrion (GO:1903955),1/113,0.0710312243296769,0.1058894710236663,0,0,14.787946428571429,39.108731340452245,NRG1
517,GO_Biological_Process_2017b,induction by virus of host protein phosphorylation (GO:0039614),1/113,0.0710312243296769,0.1058894710236663,0,0,14.787946428571429,39.108731340452245,PTK2
532,GO_Biological_Process_2017b,regulation of mesenchymal cell proliferation (GO:0010464),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
531,GO_Biological_Process_2017b,regulation of cell proliferation in bone marrow (GO:0071863),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
530,GO_Biological_Process_2017b,regulation of skeletal muscle cell proliferation (GO:0014857),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
529,GO_Biological_Process_2017b,regulation of germ cell proliferation (GO:1905936),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
528,GO_Biological_Process_2017b,regulation of fat cell proliferation (GO:0070344),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
527,GO_Biological_Process_2017b,regulation of hair follicle cell proliferation (GO:0071336),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
535,GO_Biological_Process_2017b,regulation of cell proliferation involved in imaginal disc-derived wing morphogenesis (GO:0090256),1/122,0.0764833854144393,0.1058894710236663,0,0,13.681818181818182,35.17160025020979,PTK2
525,GO_Biological_Process_2017b,regulation of synoviocyte proliferation (GO:1901645),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
524,GO_Biological_Process_2017b,regulation of cell proliferation involved in kidney development (GO:1901722),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
523,GO_Biological_Process_2017b,regulation of leukocyte proliferation (GO:0070663),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
522,GO_Biological_Process_2017b,regulation of cell proliferation (GO:0042127),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
521,GO_Biological_Process_2017b,regulation of hemocyte proliferation (GO:0035206),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
520,GO_Biological_Process_2017b,positive regulation of histone phosphorylation (GO:0033129),1/120,0.0752743529888432,0.1058894710236663,0,0,13.913165266106445,35.98801310463489,PTK2
519,GO_Biological_Process_2017b,phosphatidylinositol 3-kinase signaling (GO:0014065),1/114,0.071638483872761,0.1058894710236663,0,0,14.656342182890857,38.63591874781072,NRG1
518,GO_Biological_Process_2017b,positive regulation of activation of Janus kinase activity (GO:0010536),1/114,0.071638483872761,0.1058894710236663,0,0,14.656342182890857,38.63591874781072,PTK2
546,GO_Biological_Process_2017b,regulation of neural precursor cell proliferation (GO:2000177),1/123,0.0770873542947081,0.1058894710236663,0,0,13.568989071038253,34.77482268580042,PTK2
547,GO_Biological_Process_2017b,regulation of cell proliferation involved in kidney morphogenesis (GO:0061006),1/124,0.0776909585674449,0.1058894710236663,0,0,13.4579945799458,34.3853967516103,PTK2
545,GO_Biological_Process_2017b,regulation of cardiac muscle cell proliferation (GO:0060043),1/123,0.0770873542947081,0.1058894710236663,0,0,13.568989071038253,34.77482268580042,PTK2
549,GO_Biological_Process_2017b,regulation of stem cell proliferation (GO:0072091),1/125,0.0782941984154646,0.1058894710236663,0,0,13.348790322580646,34.003130280859715,PTK2
571,GO_Biological_Process_2017b,positive regulation of protein autophosphorylation (GO:0031954),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
570,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the cerebral cortex (GO:0021967),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
569,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the basilar pons (GO:0021970),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
568,GO_Biological_Process_2017b,photoreceptor cell axon guidance (GO:0072499),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
567,GO_Biological_Process_2017b,sympathetic neuron axon guidance (GO:0097492),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
566,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the cerebral peduncle (GO:0021969),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
565,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the internal capsule (GO:0021968),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
548,GO_Biological_Process_2017b,regulation of osteoblast proliferation (GO:0033688),1/124,0.0776909585674449,0.1058894710236663,0,0,13.4579945799458,34.3853967516103,PTK2
563,GO_Biological_Process_2017b,dorsal/ventral axon guidance (GO:0033563),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
562,GO_Biological_Process_2017b,axon choice point recognition (GO:0016198),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
561,GO_Biological_Process_2017b,semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
560,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the medullary pyramid (GO:0021971),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
564,GO_Biological_Process_2017b,serotonergic neuron axon guidance (GO:0036515),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
550,GO_Biological_Process_2017b,regulation of growth plate cartilage chondrocyte proliferation (GO:0003420),1/126,0.0788970740354205,0.1058894710236663,0,0,13.241333333333332,33.62783759261686,PTK2
551,GO_Biological_Process_2017b,regulation of cell proliferation involved in embryonic placenta development (GO:0060723),1/127,0.0794995856538601,0.1058894710236663,0,0,13.135582010582011,33.25933922123504,PTK2
552,GO_Biological_Process_2017b,regulation of trophectodermal cell proliferation (GO:1904073),1/127,0.0794995856538601,0.1058894710236663,0,0,13.135582010582011,33.25933922123504,PTK2
553,GO_Biological_Process_2017b,regulation of smooth muscle cell proliferation (GO:0048660),1/127,0.0794995856538601,0.1058894710236663,0,0,13.135582010582011,33.25933922123504,PTK2
554,GO_Biological_Process_2017b,sensory neuron axon guidance (GO:0097374),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
555,GO_Biological_Process_2017b,interneuron axon guidance (GO:0097376),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
556,GO_Biological_Process_2017b,anterior/posterior axon guidance (GO:0033564),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
534,GO_Biological_Process_2017b,regulation of sebum secreting cell proliferation (GO:1904002),1/121,0.0758790517068621,0.1058894710236663,0,0,13.796527777777778,35.575928388462685,PTK2
558,GO_Biological_Process_2017b,olfactory bulb axon guidance (GO:0071678),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
559,GO_Biological_Process_2017b,dopaminergic neuron axon guidance (GO:0036514),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
557,GO_Biological_Process_2017b,corticospinal neuron axon guidance through spinal cord (GO:0021972),1/128,0.0801017334683338,0.1058894710236663,0,0,13.031496062992126,32.897461671293605,PTK2
576,GO_Biological_Process_2017b,retinal ganglion cell axon guidance (GO:0031290),1/130,0.0813049384468739,0.1059704815712065,0,0,12.828165374677004,32.19290344020333,PTK2
574,GO_Biological_Process_2017b,Roundabout signaling pathway involved in axon guidance (GO:2001266),1/130,0.0813049384468739,0.1059704815712065,0,0,12.828165374677004,32.19290344020333,PTK2
573,GO_Biological_Process_2017b,corticospinal neuron axon guidance (GO:0021966),1/129,0.0807035176543198,0.1059704815712065,0,0,12.929036458333334,32.54203717343626,PTK2
575,GO_Biological_Process_2017b,commissural neuron axon guidance (GO:0071679),1/130,0.0813049384468739,0.1059704815712065,0,0,12.828165374677004,32.19290344020333,PTK2
572,GO_Biological_Process_2017b,VEGF-activated neuropilin signaling pathway involved in axon guidance (GO:1902378),1/129,0.0807035176543198,0.1059704815712065,0,0,12.929036458333334,32.54203717343626,PTK2
136,GO_Biological_Process_2018,cellular protein complex assembly (GO:0043623),1/144,0.0896867838913074,0.1065842938998146,0,0,11.564102564102564,27.886045327020614,NRG1
137,GO_Biological_Process_2018,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1/144,0.0896867838913074,0.1065842938998146,0,0,11.564102564102564,27.886045327020614,PTK2
577,GO_Biological_Process_2017b,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/133,0.0831070223634688,0.1074140901856533,0,0,12.53472222222222,31.1817018518508,PTK2
578,GO_Biological_Process_2017b,motor neuron axon guidance (GO:0008045),1/133,0.0831070223634688,0.1074140901856533,0,0,12.53472222222222,31.1817018518508,PTK2
579,GO_Biological_Process_2017b,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/133,0.0831070223634688,0.1074140901856533,0,0,12.53472222222222,31.1817018518508,PTK2
580,GO_Biological_Process_2017b,chemorepulsion of axon (GO:0061643),1/134,0.0837069915156922,0.1078890112868921,0,0,12.43984962406015,30.856210715153104,PTK2
138,GO_Biological_Process_2018,regulation of protein kinase activity (GO:0045859),1/147,0.0914736846456402,0.1079257862006114,0,0,11.324771689497718,27.08550115506136,PTK2
139,GO_Biological_Process_2018,heart development (GO:0007507),1/149,0.092663152456293,0.1085482643059433,0,0,11.170608108108109,26.57246805823029,PTK2
581,GO_Biological_Process_2017b,activation of MAPK activity (GO:0000187),1/137,0.0855047253614574,0.1099008104368871,0,0,12.163602941176473,29.91253332210957,NRG1
211,WikiPathways_2019_Human,TGF-beta Signaling Pathway WP366,1/132,0.0825066905956245,0.110008920794166,0,0,12.631043256997456,31.512885297547427,PTK2
582,GO_Biological_Process_2017b,axon extension involved in axon guidance (GO:0048846),1/139,0.086701405240232,0.1111310829598554,0,0,11.98611111111111,29.309459952738585,PTK2
140,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",2/813,0.0957376937704365,0.1113544806975289,0,0,4.299069611030154,10.08623286448024,ARID5B;NRG1
213,WikiPathways_2019_Human,Mesodermal Commitment Pathway WP2857,1/147,0.0914736846456402,0.1119088165904587,0,0,11.324771689497718,27.08550115506136,ARID5B
212,WikiPathways_2019_Human,NRF2 pathway WP2884,1/146,0.0908784111279133,0.1119088165904587,0,0,11.403448275862068,27.3481237720878,NRG1
214,WikiPathways_2019_Human,Regulation of Actin Cytoskeleton WP51,1/150,0.0932573471587156,0.1119088165904587,0,0,11.095078299776286,26.32187980921209,PTK2
583,GO_Biological_Process_2017b,chemoattraction of axon (GO:0061642),1/142,0.088493715040115,0.1131159332744169,0,0,11.729314420803783,28.4415201317001,PTK2
141,GO_Biological_Process_2018,axon guidance (GO:0007411),1/158,0.0979979899693764,0.1131807771477305,0,0,10.52547770700637,24.448667095484595,PTK2
584,GO_Biological_Process_2017b,activation of JUN kinase activity (GO:0007257),1/143,0.0890904297704159,0.1135658225644862,0,0,11.64612676056338,28.161538253712973,NRG1
585,GO_Biological_Process_2017b,protein trans-autophosphorylation (GO:0036290),1/145,0.0902827776128711,0.1138348065553592,0,0,11.483217592592592,27.61493997287688,PTK2
586,GO_Biological_Process_2017b,peptidyl-aspartic acid autophosphorylation (GO:1990938),1/145,0.0902827776128711,0.1138348065553592,0,0,11.483217592592592,27.61493997287688,PTK2
588,GO_Biological_Process_2017b,protein cis-autophosphorylation (GO:0036291),1/145,0.0902827776128711,0.1138348065553592,0,0,11.483217592592592,27.61493997287688,PTK2
587,GO_Biological_Process_2017b,peptidyl-histidine autophosphorylation (GO:0090593),1/145,0.0902827776128711,0.1138348065553592,0,0,11.483217592592592,27.61493997287688,PTK2
216,WikiPathways_2019_Human,Chemokine signaling pathway WP3929,1/164,0.1015384465657889,0.1142307523865125,0,0,10.134969325153374,23.18189541881573,PTK2
215,WikiPathways_2019_Human,EGF/EGFR Signaling Pathway WP437,1/162,0.1003597222049837,0.1142307523865125,0,0,10.261904761904765,23.592060816165063,PTK2
142,GO_Biological_Process_2018,positive regulation of protein modification process (GO:0031401),1/163,0.1009492626948692,0.1157739795941157,0,0,10.198045267489713,23.385517356838168,PTK2
173,KEGG_2019_Human,Small cell lung cancer,1/93,0.0588087686569903,0.1157893233596013,0,0,18.02083333333333,51.06138805719774,PTK2
172,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0569626505406045,0.1157893233596013,0,0,18.631086142322097,53.384759293029546,COL6A5
171,KEGG_2019_Human,ECM-receptor interaction,1/82,0.0520233153027185,0.1157893233596013,0,0,20.47942386831276,60.53847309097546,COL6A5
170,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0470601097064945,0.1157893233596013,0,0,22.732876712328768,69.47916318158998,PTK2
169,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0376893933426092,0.1157893233596013,0,0,28.63362068965517,93.87179112052809,PTK2
174,KEGG_2019_Human,Amoebiasis,1/96,0.0606515503312197,0.1157893233596013,0,0,17.449122807017545,48.903087500760165,PTK2
590,GO_Biological_Process_2017b,positive regulation of protein phosphorylation (GO:0001934),1/151,0.0938511826416481,0.1176944560695262,0,0,11.020555555555555,26.075129428578464,PTK2
589,GO_Biological_Process_2017b,ephrin receptor signaling pathway (GO:0048013),1/151,0.0938511826416481,0.1176944560695262,0,0,11.020555555555555,26.075129428578464,PTK2
143,GO_Biological_Process_2018,peptidyl-serine modification (GO:0018209),1/170,0.1050660716630017,0.1196585816161964,0,0,9.772189349112423,22.018363543847435,GALNTL6
144,GO_Biological_Process_2018,positive regulation of protein kinase activity (GO:0045860),1/172,0.1062391026375432,0.1201600885003937,0,0,9.656920077972709,21.651423585597897,PTK2
591,GO_Biological_Process_2017b,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/155,0.0962229365001757,0.120343510878926,0,0,10.732142857142858,25.12488575477612,PTK2
145,GO_Biological_Process_2018,protein autophosphorylation (GO:0046777),1/175,0.1079959881971444,0.1213105620844635,0,0,9.488984674329505,21.119265006332917,PTK2
146,GO_Biological_Process_2018,positive regulation of MAP kinase activity (GO:0043406),1/177,0.1091654735973338,0.1217900521766173,0,0,9.380208333333334,20.7761337769104,NRG1
175,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.070423598148171,0.1232412967592994,0,0,14.92192192192192,39.591244210462285,PTK2
592,GO_Biological_Process_2017b,positive regulation of GTPase activity (GO:0043547),1/160,0.0991795705264762,0.1233761949712733,0,0,10.39203354297694,24.01415249907194,PTK2
593,GO_Biological_Process_2017b,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/160,0.0991795705264762,0.1233761949712733,0,0,10.39203354297694,24.01415249907194,PTK2
147,GO_Biological_Process_2018,regulation of GTPase activity (GO:0043087),1/188,0.1155723837727469,0.1280666955319628,0,0,8.823529411764707,19.03992569985146,PTK2
594,GO_Biological_Process_2017b,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/169,0.1044790234223537,0.1296210344063426,0,0,9.830853174603174,22.20562600629432,PTK2
217,WikiPathways_2019_Human,Focal Adhesion WP306,1/198,0.1213599106401171,0.1323926297892187,0,0,8.37140439932318,17.655247344501635,PTK2
595,GO_Biological_Process_2017b,positive regulation of protein kinase activity (GO:0045860),1/176,0.1085809079251888,0.1343507767394336,0,0,9.434285714285714,20.94656426340017,PTK2
596,GO_Biological_Process_2017b,peptidyl-tyrosine autophosphorylation (GO:0038083),1/178,0.1097496853958129,0.1354357819778117,0,0,9.326741996233524,20.607931630836863,PTK2
597,GO_Biological_Process_2017b,peptidyl-threonine autophosphorylation (GO:1990443),1/181,0.1115001995438108,0.1372310148231518,0,0,9.169907407407408,20.11629087576762,PTK2
598,GO_Biological_Process_2017b,axon guidance (GO:0007411),1/182,0.1120829978352668,0.1375833624221264,0,0,9.11878453038674,19.95660247162695,PTK2
599,GO_Biological_Process_2017b,"negative regulation of transcription, DNA-templated (GO:0045892)",2/895,0.1126344750704148,0.1378955050993997,0,0,3.8876107095591976,8.489015658414479,ARID5B;NRG1
148,GO_Biological_Process_2018,positive regulation of phosphorylation (GO:0042327),1/208,0.1271124608572515,0.1399090173193909,0,0,7.962962962962963,16.425068857318326,PTK2
176,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.086701405240232,0.1400561161572979,0,0,11.98611111111111,29.309459952738585,PTK2
600,GO_Biological_Process_2017b,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/189,0.1161527159532597,0.1418285794797698,0,0,8.776152482269504,18.893734929477525,ARID5B
149,GO_Biological_Process_2018,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),1/215,0.1311185387258581,0.1433562690069382,0,0,7.699766355140187,15.643257181170846,ARID5B
178,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.1144106640708809,0.1436526765633942,0,0,8.91981981981982,19.337821380243447,PTK2
177,KEGG_2019_Human,Axon guidance,1/181,0.1115001995438108,0.1436526765633942,0,0,9.169907407407408,20.11629087576762,PTK2
179,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.1167326966106238,0.1436526765633942,0,0,8.729276895943563,18.749339765752254,PTK2
183,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.1368120729175183,0.1436526765633942,0,0,7.352306547619047,14.624818698780198,PTK2
180,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.1230893394222186,0.1436526765633942,0,0,8.244583333333333,17.27112294033994,PTK2
181,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.129403730926868,0.1436526765633942,0,0,7.81042654028436,15.970901283526263,PTK2
182,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.1305472828644177,0.1436526765633942,0,0,7.736306729264475,15.751273656768497,PTK2
601,GO_Biological_Process_2017b,positive regulation of MAPK cascade (GO:0043410),1/194,0.1190491079826504,0.144983690561548,0,0,8.546632124352332,18.189106572753214,PTK2
150,GO_Biological_Process_2018,axonogenesis (GO:0007409),1/223,0.1356761286696523,0.1473568549789601,0,0,7.4192942942942945,14.819926393575225,PTK2
218,WikiPathways_2019_Human,VEGFA-VEGFR2 Signaling Pathway WP3888,1/236,0.1430351717822827,0.1514490054165346,0,0,7.004255319148936,13.620928226147496,PTK2
151,GO_Biological_Process_2018,activation of protein kinase activity (GO:0032147),1/233,0.1413420831024722,0.1525006686105621,0,0,7.095905172413793,13.883650833851748,NRG1
602,GO_Biological_Process_2017b,planar cell polarity pathway involved in axon guidance (GO:1904938),1/213,0.1299756803283623,0.1578762190375919,0,0,7.773191823899371,15.860482164462194,PTK2
603,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),2/991,0.133385887539571,0.1615954355570782,0,0,3.492600422832981,7.035874781424263,ARID5B;NRG1
152,GO_Biological_Process_2018,regulation of protein phosphorylation (GO:0001932),1/261,0.1570248736583684,0.1683142436599504,0,0,6.32275641025641,11.70564175213891,PTK2
604,GO_Biological_Process_2017b,peptidyl-serine autophosphorylation (GO:0036289),1/240,0.1452878299014321,0.1755561277975638,0,0,6.885634588563459,13.282654014006903,PTK2
607,GO_Biological_Process_2017b,nervous system development (GO:0007399),1/244,0.1475350209692452,0.1768895341853482,0,0,6.770919067215363,12.957438085806086,NRG1
605,GO_Biological_Process_2017b,stomatogastric nervous system development (GO:0007421),1/244,0.1475350209692452,0.1768895341853482,0,0,6.770919067215363,12.957438085806086,NRG1
606,GO_Biological_Process_2017b,ganglion development (GO:0061548),1/244,0.1475350209692452,0.1768895341853482,0,0,6.770919067215363,12.957438085806086,NRG1
608,GO_Biological_Process_2017b,autonomic nervous system development (GO:0048483),1/245,0.1480959659556243,0.1771044541324992,0,0,6.742827868852459,12.878091861977191,NRG1
153,GO_Biological_Process_2018,negative regulation of signal transduction (GO:0009968),1/283,0.169161112719078,0.1801456005579791,0,0,5.822990543735225,10.346893375208618,NRG1
609,GO_Biological_Process_2017b,positive regulation of I-kappaB phosphorylation (GO:1903721),1/252,0.1520130506430728,0.1813214794302976,0,0,6.552456839309429,12.343445476872184,PTK2
610,GO_Biological_Process_2017b,peripheral nervous system development (GO:0007422),1/255,0.1536867062383487,0.1828477735758815,0,0,6.474081364829396,12.12491287069092,NRG1
611,GO_Biological_Process_2017b,neural tube development (GO:0021915),1/259,0.1559135040600901,0.1850226748948384,0,0,6.372416020671834,11.84284132100842,NRG1
219,WikiPathways_2019_Human,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,1/303,0.1800538929346244,0.1851982898756137,0,0,5.431843267108167,9.312890217416603,PTK2
220,WikiPathways_2019_Human,Nuclear Receptors Meta-Pathway WP2882,1/319,0.1886730364486996,0.1886730364486996,0,0,5.154350104821803,8.596114441427202,NRG1
612,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion by transcription from RNA polymerase II promoter (GO:0100017),1/268,0.1609040390836522,0.1904578421806496,0,0,6.154806491885144,11.244506008237057,PTK2
613,GO_Biological_Process_2017b,determination of left/right asymmetry in nervous system (GO:0035545),1/270,0.1620093416434566,0.19127820489202,0,0,6.108426270136308,11.117954478842362,NRG1
614,GO_Biological_Process_2017b,neurogenesis (GO:0022008),1/272,0.1631133000996947,0.1920928204219755,0,0,6.062730627306273,10.993611450066114,NRG1
615,GO_Biological_Process_2017b,synapse assembly (GO:0007416),1/285,0.1702563709906357,0.1999973573155822,0,0,5.781396713615023,10.235673310191205,NRG1
616,GO_Biological_Process_2017b,regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1/322,0.1902797849733878,0.2199738193730749,0,0,5.10539979231568,8.471184319089176,PTK2
619,GO_Biological_Process_2017b,negative regulation of myofibroblast cell apoptotic process (GO:1904521),1/325,0.1918835958390138,0.2199738193730749,0,0,5.057355967078189,8.34901884915279,PTK2
618,GO_Biological_Process_2017b,negative regulation of compound eye retinal cell apoptotic process (GO:1901693),1/325,0.1918835958390138,0.2199738193730749,0,0,5.057355967078189,8.34901884915279,PTK2
617,GO_Biological_Process_2017b,negative regulation of fat cell apoptotic process (GO:1904650),1/325,0.1918835958390138,0.2199738193730749,0,0,5.057355967078189,8.34901884915279,PTK2
622,GO_Biological_Process_2017b,negative regulation of apoptotic process involved in development (GO:1904746),1/325,0.1918835958390138,0.2199738193730749,0,0,5.057355967078189,8.34901884915279,PTK2
623,GO_Biological_Process_2017b,negative regulation of fibroblast apoptotic process (GO:2000270),1/326,0.1924175474831785,0.2199738193730749,0,0,5.041538461538462,8.30889672983731,PTK2
624,GO_Biological_Process_2017b,negative regulation of muscle cell apoptotic process (GO:0010656),1/326,0.1924175474831785,0.2199738193730749,0,0,5.041538461538462,8.30889672983731,PTK2
625,GO_Biological_Process_2017b,negative regulation of mesenchymal cell apoptotic process (GO:2001054),1/327,0.1929511734587101,0.2199738193730749,0,0,5.02581799591002,8.26906936294022,PTK2
626,GO_Biological_Process_2017b,negative regulation of myeloid cell apoptotic process (GO:0033033),1/327,0.1929511734587101,0.2199738193730749,0,0,5.02581799591002,8.26906936294022,PTK2
627,GO_Biological_Process_2017b,peptidyl-tyrosine phosphorylation (GO:0018108),1/327,0.1929511734587101,0.2199738193730749,0,0,5.02581799591002,8.26906936294022,PTK2
620,GO_Biological_Process_2017b,negative regulation of apoptotic process in bone marrow (GO:0071866),1/325,0.1918835958390138,0.2199738193730749,0,0,5.057355967078189,8.34901884915279,PTK2
621,GO_Biological_Process_2017b,negative regulation of epithelial cell apoptotic process (GO:1904036),1/325,0.1918835958390138,0.2199738193730749,0,0,5.057355967078189,8.34901884915279,PTK2
628,GO_Biological_Process_2017b,negative regulation of glial cell apoptotic process (GO:0034351),1/330,0.1945500991398207,0.2207120929116792,0,0,4.979229989868288,8.151325981357527,PTK2
629,GO_Biological_Process_2017b,negative regulation of execution phase of apoptosis (GO:1900118),1/330,0.1945500991398207,0.2207120929116792,0,0,4.979229989868288,8.151325981357527,PTK2
630,GO_Biological_Process_2017b,negative regulation of leukocyte apoptotic process (GO:2000107),1/331,0.1950824242210529,0.2207762069233379,0,0,4.963888888888889,8.112648022124281,PTK2
154,GO_Biological_Process_2018,post-translational protein modification (GO:0043687),1/357,0.2088094118508588,0.2209338293131667,0,0,4.595271535580524,7.197727049641736,ASB3
631,GO_Biological_Process_2017b,central nervous system development (GO:0007417),1/333,0.1961461002401408,0.2214398795898426,0,0,4.933483935742972,8.03612972326308,NRG1
632,GO_Biological_Process_2017b,negative regulation of anoikis (GO:2000811),1/336,0.1977391816974161,0.2226965541446628,0,0,4.888557213930349,7.92340472523022,PTK2
633,GO_Biological_Process_2017b,negative regulation of apoptotic signaling pathway (GO:2001234),1/338,0.1987996164012972,0.2233487215743388,0,0,4.859050445103858,7.8495914976837105,PTK2
634,GO_Biological_Process_2017b,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/346,0.2030284295940769,0.227548771332492,0,0,4.7444444444444445,7.564586167565773,PTK2
635,GO_Biological_Process_2017b,N-terminal protein amino acid propionylation (GO:0061606),1/355,0.2077612118695875,0.2311779431834259,0,0,4.621704331450094,7.262388487502373,ASB3
636,GO_Biological_Process_2017b,C-terminal protein amino acid modification (GO:0018410),1/355,0.2077612118695875,0.2311779431834259,0,0,4.621704331450094,7.262388487502373,ASB3
637,GO_Biological_Process_2017b,CAAX-box protein modification (GO:0071587),1/355,0.2077612118695875,0.2311779431834259,0,0,4.621704331450094,7.262388487502373,ASB3
638,GO_Biological_Process_2017b,protein autophosphorylation (GO:0046777),1/358,0.2093330316529737,0.2323696810693297,0,0,4.582166199813258,7.165723663623585,PTK2
639,GO_Biological_Process_2017b,post-translational protein acetylation (GO:0034421),1/368,0.2145516647092089,0.2375942062650904,0,0,4.455040871934605,6.857219886647275,ASB3
640,GO_Biological_Process_2017b,canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336),1/371,0.2161110433440563,0.2387512478848622,0,0,4.418243243243243,6.768584792976873,PTK2
155,GO_Biological_Process_2018,negative regulation of programmed cell death (GO:0043069),1/408,0.235109859848123,0.2471667757377703,0,0,4.009009009009009,5.803851905277552,PTK2
641,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process (GO:0043524),1/399,0.2305280576997125,0.2534716084660346,0,0,4.101549413735343,6.018542647065694,PTK2
642,GO_Biological_Process_2017b,negative regulation of cell proliferation (GO:0008285),1/399,0.2305280576997125,0.2534716084660346,0,0,4.101549413735343,6.018542647065694,PTK2
643,GO_Biological_Process_2017b,post-translational protein modification (GO:0043687),1/429,0.2457029699669599,0.2695181514531192,0,0,3.808216510903427,5.345334221558989,ASB3
156,GO_Biological_Process_2018,nervous system development (GO:0007399),1/455,0.2586306001016927,0.2701619007431695,0,0,3.585352422907489,4.848667446581206,NRG1
157,GO_Biological_Process_2018,protein phosphorylation (GO:0006468),1/470,0.2659955013575343,0.2760965963457951,0,0,3.468017057569297,4.592611349552671,PTK2
677,GO_Biological_Process_2017b,negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633),1/484,0.2728084184031025,0.2762698605273001,0,0,3.365079365079365,4.371189282204637,ARID5B
658,GO_Biological_Process_2017b,negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter (GO:0035952),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
659,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034396),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
660,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072365),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
661,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
662,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046020),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
663,GO_Biological_Process_2017b,regulation of transport by negative regulation of transcription from RNA polymerase II promoter (GO:1900392),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
664,GO_Biological_Process_2017b,transfer RNA gene-mediated silencing (GO:0061587),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
665,GO_Biological_Process_2017b,negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter (GO:1902625),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
667,GO_Biological_Process_2017b,negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter (GO:1900474),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
657,GO_Biological_Process_2017b,negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900473),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
668,GO_Biological_Process_2017b,negative regulation of snRNA transcription from RNA polymerase II promoter (GO:1905381),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
669,GO_Biological_Process_2017b,negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900471),1/482,0.2718387316404644,0.2762698605273001,0,0,3.3794178794178795,4.401848210721037,ARID5B
670,GO_Biological_Process_2017b,negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581),1/482,0.2718387316404644,0.2762698605273001,0,0,3.3794178794178795,4.401848210721037,ARID5B
671,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0007070),1/482,0.2718387316404644,0.2762698605273001,0,0,3.3794178794178795,4.401848210721037,ARID5B
672,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903758),1/482,0.2718387316404644,0.2762698605273001,0,0,3.3794178794178795,4.401848210721037,ARID5B
673,GO_Biological_Process_2017b,negative regulation of mitochondrial unfolded protein response by negative regulation of transcription from RNA polymerase II promoter (GO:1904490),1/483,0.2723237241106384,0.2762698605273001,0,0,3.3722337482710927,4.386479443917246,ARID5B
666,GO_Biological_Process_2017b,negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter (GO:1900460),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
656,GO_Biological_Process_2017b,carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
654,GO_Biological_Process_2017b,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)",1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
676,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter (GO:0035949),1/484,0.2728084184031025,0.2762698605273001,0,0,3.365079365079365,4.371189282204637,ARID5B
678,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820),1/484,0.2728084184031025,0.2762698605273001,0,0,3.365079365079365,4.371189282204637,ARID5B
679,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/485,0.2732928146164456,0.2762698605273001,0,0,3.3579545454545454,4.355977177584417,ARID5B
674,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768),1/484,0.2728084184031025,0.2762698605273001,0,0,3.365079365079365,4.371189282204637,ARID5B
644,GO_Biological_Process_2017b,negative regulation of apoptotic process (GO:0043066),1/467,0.2645279464357051,0.2762698605273001,0,0,3.49087982832618,4.642201234142023,PTK2
655,GO_Biological_Process_2017b,negative regulation of cellular response to alkaline pH by negative regulation of transcription from RNA polymerase II promoter (GO:1900463),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
646,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010674),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
645,GO_Biological_Process_2017b,negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter (GO:1900464),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
648,GO_Biological_Process_2017b,negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter (GO:1900462),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
649,GO_Biological_Process_2017b,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter (GO:0072368),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
650,GO_Biological_Process_2017b,negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by negative regulation of transcription from RNA polymerase II promoter (GO:1902352),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
651,GO_Biological_Process_2017b,negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0010688),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
652,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061398),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
653,GO_Biological_Process_2017b,negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900526),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
647,GO_Biological_Process_2017b,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072362),1/481,0.2713534408139282,0.2762698605273001,0,0,3.3866319444444444,4.417296136558944,ARID5B
675,GO_Biological_Process_2017b,negative regulation of ceramide biosynthetic process by negative regulation of transcription from RNA Polymerase II promoter (GO:0061427),1/484,0.2728084184031025,0.2762698605273001,0,0,3.365079365079365,4.371189282204637,ARID5B
681,GO_Biological_Process_2017b,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/488,0.2747442168651562,0.27653214018532,0,0,3.3367556468172483,4.3108037860043495,ARID5B
680,GO_Biological_Process_2017b,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),1/487,0.2742607136992734,0.27653214018532,0,0,3.343792866941015,4.325784965941279,ARID5B
682,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904489),1/492,0.2766752576203918,0.2778729860083588,0,0,3.3088934147997286,4.2516329366803856,ARID5B
683,GO_Biological_Process_2017b,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477),1/496,0.2786015513395033,0.2792032825518996,0,0,3.2814814814814817,4.193643582557186,ARID5B
158,GO_Biological_Process_2018,negative regulation of apoptotic process (GO:0043066),1/485,0.2732928146164456,0.2818869282836294,0,0,3.3579545454545454,4.355977177584417,PTK2
159,GO_Biological_Process_2018,"regulation of transcription, DNA-templated (GO:0006355)",2/1598,0.2788693504755026,0.2858410842373901,0,0,2.0951241740715423,2.6754984702172333,ARID5B;NRG1
184,KEGG_2019_Human,Pathways in cancer,1/530,0.2947848944372047,0.2947848944372047,0,0,3.065217391304348,3.744191733963282,PTK2
684,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904089),1/534,0.2966666222161576,0.2966666222161576,0,0,3.041588492808005,3.6959748655483926,ARID5B
160,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/565,0.3110936284372161,0.3168904041223817,0,0,2.869828605200946,3.3509879607598374,ARID5B
161,GO_Biological_Process_2018,regulation of apoptotic process (GO:0042981),1/815,0.4178405392739505,0.4229990644501721,0,0,1.962837837837838,1.7128810468199294,PTK2
162,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),1/1001,0.4871138372018184,0.4901022656509093,0,0,1.58225,1.1380450706124423,ASB3
163,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),1/1478,0.6315163687074364,0.6315163687074364,0,0,1.0443466486120514,0.4800145301155456,ARID5B
